Plant ID: NPO1680
Plant Latin Name: Physalis Angulata
Taxonomy Genus: Physalis
Taxonomy Family: Solanaceae
NCBI TaxonomyDB:
113208
Plant-of-the-World-Online:
n.a.
Diuretic; Expectorant; Febrifuge
Brazil; Ghana; Indonesia; India; Kenya; Bolivia
Ingredient ID: NPC83438
Ingredient ID: NPC75844
Ingredient ID: NPC64449
Ingredient ID: NPC62608
Ingredient ID: NPC484714
Ingredient ID: NPC484713
Ingredient ID: NPC484712
Ingredient ID: NPC484711
Ingredient ID: NPC484710
Ingredient ID: NPC484709
Ingredient ID: NPC484708
Ingredient ID: NPC484707
Ingredient ID: NPC484706
Ingredient ID: NPC484705
Ingredient ID: NPC484704
Ingredient ID: NPC484703
Ingredient ID: NPC484702
Ingredient ID: NPC484701
Ingredient ID: NPC484700
Ingredient ID: NPC484699
Ingredient ID: NPC484698
Ingredient ID: NPC484697
Ingredient ID: NPC484695
Ingredient ID: NPC484694
Ingredient ID: NPC484693
Ingredient ID: NPC484692
Ingredient ID: NPC484691
Ingredient ID: NPC484690
Ingredient ID: NPC41988
Ingredient ID: NPC33378
Ingredient ID: NPC331672
Ingredient ID: NPC331613
Ingredient ID: NPC329671
Ingredient ID: NPC326856
Ingredient ID: NPC325599
Ingredient ID: NPC307753
Ingredient ID: NPC297292
Ingredient ID: NPC264192
Ingredient ID: NPC261333
Ingredient ID: NPC254146
Ingredient ID: NPC246093
Ingredient ID: NPC243014
Ingredient ID: NPC232533
Ingredient ID: NPC192237
Ingredient ID: NPC18509
Ingredient ID: NPC18074
Ingredient ID: NPC168799
Ingredient ID: NPC166213
Ingredient ID: NPC164523
Ingredient ID: NPC162313
Ingredient ID: NPC158319
Ingredient ID: NPC144739
Ingredient ID: NPC125159
Ingredient ID: NPC100390
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 5 | TBXAS1 | Thromboxane-A synthase | P24557 | CHEMBL1835 |
Therapeutic Target | GABA-A receptor | GABRA3 | GABA receptor alpha-3 subunit | P34903 | CHEMBL3026 |
Therapeutic Target | GABA-A receptor | GABRA1 | GABA receptor alpha-1 subunit | P14867 | CHEMBL1962 |
Therapeutic Target | GABA-A receptor | GABRA5 | GABA receptor alpha-5 subunit | P31644 | CHEMBL5112 |
Therapeutic Target | GABA-A receptor | GABRA2 | GABA receptor alpha-2 subunit | P47869 | CHEMBL4956 |
Therapeutic Target | Metallo protease | MMP9 | Matrix metalloproteinase 9 | P14780 | CHEMBL321 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | PGR | Progesterone receptor | P06401 | CHEMBL208 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | AR | Androgen Receptor | P10275 | CHEMBL1871 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C2 | Mineralocorticoid receptor | P08235 | CHEMBL1994 |
Therapeutic Target | Oxidoreductase | PTGS2 | Cyclooxygenase-2 | P35354 | CHEMBL230 |
Therapeutic Target | Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Therapeutic Target | Oxidoreduction-driven transporters | COX2 | Cytochrome c oxidase subunit 2 | P00403 | CHEMBL6174 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Peptide receptor (family A GPCR) | OPRM1 | Mu opioid receptor | P35372 | CHEMBL233 |
Therapeutic Target | Peptide receptor (family A GPCR) | OPRD1 | Delta opioid receptor | P41143 | CHEMBL236 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Therapeutic Target | Secreted protein | SERPINA6 | Corticosteroid binding globulin | P08185 | CHEMBL2421 |
Therapeutic Target | Secreted protein | CXCL8 | Interleukin-8 | P10145 | CHEMBL2157 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | GLI1 | Zinc finger protein GLI1 | P08151 | CHEMBL5461 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Therapeutic Target | Transcription factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 1651 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01946074 | A Study of ABT-165 in Subjects With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02721069 | Repeat Dose Safety Study of NRL-1 in Epilepsy Subjects | Seizure | Diazepam (NPC325599) | NP level |
NCT00358748 | Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants | hypotension | Hydrocortisone (NPC18509) | NP level |
NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03002064 | Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01064986 | The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers | infection | Hydrocortisone (NPC18509) | NP level |
NCT05375305 | A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery | pain | Morphine (NPC232533) | NP level |
NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02551991 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01047293 | RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00541125 | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03428529 | Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03710187 | HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00766506 | An Efficacy and Safety Study to Compare Fentanyl Ionsys and Routine Care With Intravenous (IV) Morphine Patient-controlled Analgesia (PCA) in Participants Who Have Undergone Elective Major Abdominal or Orthopedic Surgery | pain | Morphine (NPC232533) | NP level |
NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00832299 | Neo-Adjuvant FOLFOX for Rectal Carcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03071276 | Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia | acute myeloid leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00737997 | Effect of Early Morphine Administration on the Development of Acute Opioid Tolerance During Pediatric Scoliosis Surgery | scoliosis | Morphine (NPC232533) | NP level |
NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02083315 | Pharmacokinetics and Pharmacodynamics of TRV130, Morphine, and Placebo in Healthy Subjects | pain | Morphine (NPC232533) | NP level |
NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002921 | S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery | adrenal cortex carcinoma | Hydrocortisone (NPC18509) | NP level |
NCT04292743 | Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003215 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00393068 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00016952 | Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01680939 | Investigating the Safety of Post-surgical Analgesics in Children With Obstructive Sleep Apnea | obstructive sleep apnea | Morphine (NPC232533) | NP level |
NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00021398 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01807429 | Is Analgesic Effect of Low Dose Ketamine-midazolam the Same as Morphine | multiple bone fractures | Morphine (NPC232533) | NP level |
NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05281081 | Intraperitoneal Instillation of Levobupivacaine With Morphine Versus Levobupivacaine With Magnesium Sulfate for Postoperative Analgesia | pain | Morphine (NPC232533) | NP level |
NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00362219 | Topical Morphine for Analgesia in Patients With Skin Grafts | pain | Morphine (NPC232533) | NP level |
NCT03387111 | QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002785 | Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02152410 | Acupuncture Versus IV Morphine in the Treatment of Acute Pain in ED | Renal Colic | Morphine (NPC232533) | NP level |
NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT05329766 | A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00019409 | Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02460913 | Acupuncture Versus Intravenous Morphine in the Management of Acute Pain in the Emergency Department | pain | Morphine (NPC232533) | NP level |
NCT00772187 | Intraoperative and Postoperative Analgesia for Laparoscopic Surgery. | pain | Morphine (NPC232533) | NP level |
NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00089024 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05037539 | Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain | pain | Morphine (NPC232533) | NP level |
NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01450930 | Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency | primary adrenal insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT03391843 | Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05193292 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00795223 | Comparative Pain Control Between 0.2 or 0.3 Spinal Morphine and 0.25 or 0.5 % Bupivacaine for FNB After TKA | pain | Morphine (NPC232533) | NP level |
NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03622489 | Comparing Protocols for Analgesia Following Elective Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT01171482 | Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02588105 | Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00041262 | Combination Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02904265 | Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome | Landau-Kleffner syndrome;status epilepticus | Diazepam (NPC325599) | NP level |
NCT02137525 | Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain | pain | Morphine (NPC232533) | NP level |
NCT02722200 | Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger | obesity | Hydrocortisone (NPC18509) | NP level |
NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03349281 | Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01498783 | Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma | central nervous system cancer;ependymoma | Fluorouracil (NPC75844) | NP level |
NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01233843 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05325164 | Methadone for 'Adenocarcinopathic' Pain Treatment | adenocarcinoma | Morphine (NPC232533) | NP level |
NCT04990037 | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066846 | Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT02494583 | Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00427570 | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01653470 | Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens | cancer | Fluorouracil (NPC75844) | NP level |
NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02335294 | A Study of TRV130 for the Treatment of Pain After Abdominoplasty | pain | Morphine (NPC232533) | NP level |
NCT03837977 | Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01383343 | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02790099 | Comparison of Surgical Rectus Sheath Block and Intrathecal Morphine | pain | Morphine (NPC232533) | NP level |
NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02172976 | Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00046995 | Combination Chemotherapy in Treating Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05413902 | Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery | pain | Morphine (NPC232533) | NP level |
NCT01453686 | A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata | alopecia areata | Hydrocortisone (NPC18509) | NP level |
NCT04061330 | Comparison of Low-dose Ketamine to Opioids in the Management of Acute Pain in Patients Presenting to the Emergency Department With Long Bone Fractures | pain | Morphine (NPC232533) | NP level |
NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03586869 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02223533 | Multimodal Analgesia With Interfascial Continuous Wound Infiltration: A Randomized Clinical Trial | pain | Morphine (NPC232533) | NP level |
NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01338558 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) | hypopharyngeal carcinoma;laryngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02749162 | Perineural Dexamethasone in Femural Nerve Block After Ligament Reconstruction | pain | Morphine (NPC232533) | NP level |
NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05222152 | Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency | primary adrenal insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02009722 | Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose | pain | Morphine (NPC232533) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | gastrointestinal stromal tumor;esophageal cancer;gastric cancer;pancreatic carcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05099055 | Dexmedetomine as Adjuvant for Spinal Anesthesia in Elective Cesarian Sections : a Pilot Study | pain | Morphine (NPC232533) | NP level |
NCT03241485 | Trial Comparing Intrathecal Morphine With Placebo In Patients Undergoing Robotic Cardiac Surgery | pain | Morphine (NPC232533) | NP level |
NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02019355 | Actinic Keratosis Study | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00673127 | Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03736720 | Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin | pancreatic endocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02669004 | Intermittent Epidural Bolus Versus Epidural Infusion for Posterior Spinal Fusion After Adolescent Idiopathic Scoliosis | pain | Morphine (NPC232533) | NP level |
NCT00872885 | Bunionectomy Trial With GRT6005 | pain | Morphine (NPC232533) | NP level |
NCT04834206 | Nedaplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04149015 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02014714 | Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea | obstructive sleep apnea | Morphine (NPC232533) | NP level |
NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05348811 | HAIC Combined With Donafenib and Sintilimab for Unresectable ICC | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT03570541 | TQL-block for Laparoscopic Hemicolectomy | pain | Morphine (NPC232533) | NP level |
NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03554109 | QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01524094 | Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002884 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04527393 | Individualized Analgesia for Pediatric Adenotonsillectomy | pain | Morphine (NPC232533) | NP level |
NCT00601627 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00519818 | Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia | classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency | Hydrocortisone (NPC18509) | NP level |
NCT01686802 | Post-operative Oral Morphine Versus Ibuprofen | pain | Morphine (NPC232533) | NP level |
NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT04766463 | A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery. | pain | Morphine (NPC232533) | NP level |
NCT00303628 | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00193219 | Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03426904 | Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002757 | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01836432 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003627 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01859312 | Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00710736 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00266539 | A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Scheduled Abdominal or Pelvic Surgery: The Fentanyl Transdermal System Versus the Morphine Intravenous Pump | pain | Morphine (NPC232533) | NP level |
NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00165178 | Treatment of Acute Lymphoblastic Leukemia in Children | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00988897 | Colorectal Cancer RECHALLENGE | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01298297 | Efficacy of Buprenorphine for Treatment of Acute Pain | pain | Morphine (NPC232533) | NP level |
NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02246049 | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00671372 | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00199797 | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04004871 | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT02359968 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04749108 | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01071057 | Naloxone for the Treatment of Opioid-Induced Pruritus | Pruritus | Morphine (NPC232533) | NP level |
NCT02474407 | Bioavailability, Safety and Tolerability of Diazepam Nasal Spray Versus Diazepam Rectal Gel (Diastat®) | epilepsy | Diazepam (NPC325599) | NP level |
NCT02369939 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02625610 | Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006103 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00656773 | A Randomized, Double-blind Comparison of Morphine and Sufentanil for Prehospital Traumatic Severe Acute Pain | pain | Morphine (NPC232533) | NP level |
NCT00460265 | Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002816 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02704520 | Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01442935 | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01465451 | Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00121563 | Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect | pain | Diazepam (NPC325599) | NP level |
NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00640822 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds | psoriasis vulgaris | Hydrocortisone (NPC18509) | NP level |
NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02590367 | Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | peripheral neuropathy | Fluorouracil (NPC75844) | NP level |
NCT03387592 | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03263689 | Transversus Abdominis Plane Block Versus Spinal Morphine After Caesarean Section : A Comparison Study | pregnancy | Morphine (NPC232533) | NP level |
NCT04359511 | Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia | COVID-19 | Hydrocortisone (NPC18509) | NP level |
NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00374881 | A Study of the Safety and Efficacy of Combination Therapy With Morphine, Phenylephrine and Sorbitol in Human Subjects | pain | Morphine (NPC232533) | NP level |
NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04821284 | Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04611724 | Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients | cancer | Fluorouracil (NPC75844) | NP level |
NCT02115152 | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03771846 | HAIC Versus Systemic Chemotherapy for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02319018 | Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03933397 | Comparing Individualized vs. Weight Based Protocols to Treat VOE in SCD Occlusive Episodes in Sickle Cell Disease | sickle cell anemia | Morphine (NPC232533) | NP level |
NCT04752696 | Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT02419755 | Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies | acute leukemia of ambiguous lineage;acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02096510 | Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01077752 | Local Anesthetic Continuous Preperitoneal Infiltration and Wound Hyperalgesia | pain | Morphine (NPC232533) | NP level |
NCT04757363 | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00027859 | Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT00732277 | Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis - a Randomised Pilot Study | Sepsis | Hydrocortisone (NPC18509) | NP level |
NCT01082471 | An Efficacy and Safety Study to Compare Morphine 6-glucuronide (M6G) and Morphine in Patients Suffering With Post-Operative Pain for at Least 24 Hours | pain | Morphine (NPC232533) | NP level |
NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04769414 | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis;neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002494 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03641976 | A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00728832 | A Pharmacokinetic (PK) Study of Extended-Release Epidural Morphine in Upper Abdominal Surgery | pain | Morphine (NPC232533) | NP level |
NCT00691002 | Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds | psoriasis vulgaris | Hydrocortisone (NPC18509) | NP level |
NCT03509350 | Vitamin C, Thiamine, and Steroids in Sepsis | Sepsis | Hydrocortisone (NPC18509) | NP level |
NCT02530151 | Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy | pain | Morphine (NPC232533) | NP level |
NCT02152514 | RCT Comparing Analgesia Post-VATS With Epimorph VS Placebo | pain | Morphine (NPC232533) | NP level |
NCT00590018 | Corticosteroids in Postoperative Critically Ill Neonates With Low Cardiac Output Syndrome With Congenital Heart Disease | heart failure | Hydrocortisone (NPC18509) | NP level |
NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02256865 | Hormonal Mechanisms of Sleep Restriction | insulin resistance | Hydrocortisone (NPC18509) | NP level |
NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05308420 | PENG Block vs Intrathecal Morphine in Total Hip Arthroplasty | pain | Morphine (NPC232533) | NP level |
NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05063994 | Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03288428 | Analgesia Comparison of Nalbuphine and Morphine for Laparoscopic Myomectomy | pain | Morphine (NPC232533) | NP level |
NCT00002744 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03306121 | TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00379262 | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00536991 | Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer | prostate adenocarcinoma | Hydrocortisone (NPC18509) | NP level |
NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03209102 | Emotional Regulation and Impulsivity Among Adolescents With Borderline Personality Disorder | Borderline personality disorder | Hydrocortisone (NPC18509) | NP level |
NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03875274 | Morphine Added to Ropivacaine for FICB for Postoperative Analgesia | pain | Morphine (NPC232533) | NP level |
NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02282956 | Ultrasound Guided Single Shot Block of Posterior Tibial Nerve for Postoperative Pain Relief After Hallux Valgus Surgery | pain | Morphine (NPC232533) | NP level |
NCT02767219 | The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01533155 | Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118 | Constipation | Morphine (NPC232533) | NP level |
NCT04832776 | FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00145769 | A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00319501 | Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. | complex partial epilepsy;Seizure | Diazepam (NPC325599) | NP level |
NCT01913158 | Safety and Efficacy Study of Anucort HC TM 25mg Rectal Suppositories to Treat Symptomatic Internal Hemorrhoids | hemorrhoid | Hydrocortisone (NPC18509) | NP level |
NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00268333 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03941093 | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02749409 | Early Parecoxib Usage to Decreases Narcotic Requirement and Length of Stay After Traumatic Rib Fracture | rib fracture | Morphine (NPC232533) | NP level |
NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | multiple myeloma | Hydrocortisone (NPC18509) | NP level |
NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004669 | Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia | bronchopulmonary dysplasia | Hydrocortisone (NPC18509) | NP level |
NCT03246620 | Oral Olanzapine Versus Haloperidol or Diazepam | Agitation | Diazepam (NPC325599) | NP level |
NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00025090 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03713216 | Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy | pain | Morphine (NPC232533) | NP level |
NCT02959879 | Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03818919 | Nonopioid Analgesia After Rotator Cuff Repair | rotator cuff tear | Diazepam (NPC325599) | NP level |
NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04161755 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002760 | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00000122 | Fluorouracil Filtering Surgery Study (FFSS) | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03502642 | Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery | pain | Morphine (NPC232533) | NP level |
NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05446467 | Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00943137 | The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT01572324 | Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT02353754 | Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT02514278 | Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00952029 | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006455 | Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00009737 | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03167164 | QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT00098839 | Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) | childhood acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02746263 | Multicenter Study to Compare Intravenous and Oral Acetaminophen for the Treatment of Acute Moderate to Severe Pain | pain | Morphine (NPC232533) | NP level |
NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05035381 | PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | basal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01451515 | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma | lymphoblastic lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03806309 | Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00349076 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT02887313 | FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01057381 | Dexmedetomidine in Pediatric Tonsillectomy | pain | Morphine (NPC232533) | NP level |
NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03534869 | Auricular Acupuncture as Effective Pain Relief After Episiotomy | pain | Morphine (NPC232533) | NP level |
NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00899847 | Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG | multiple myeloma | Hydrocortisone (NPC18509) | NP level |
NCT05469061 | Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00075595 | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02523846 | Patient Re-education vs. Background Morphine to IV-PCA in Patient With Unsatisfactory Analgesia Post Laparotomy | pain | Morphine (NPC232533) | NP level |
NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04755712 | Comparison of Two Analgesic Strategies After Scheduled Caesarean | pain | Morphine (NPC232533) | NP level |
NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00507091 | Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02880540 | Dexmedetomidine to Treat Bariatric Surgery-associated Pain | obesity | Morphine (NPC232533) | NP level |
NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05108428 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00045747 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03323463 | Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma | oropharynx squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04370418 | A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | cancer | Fluorouracil (NPC75844) | NP level |
NCT02151682 | A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain | pain | Morphine (NPC232533) | NP level |
NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03098420 | Dose Escalation of Dexamethasone to Increase Duration of Transversus Abdominal Plane Block Following Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | colorectal adenocarcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04164238 | Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02456714 | Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01322191 | Morphine PK Subgroup Analysis | pain | Morphine (NPC232533) | NP level |
NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04582786 | Dose Finding Study of STR-324 | pain | Morphine (NPC232533) | NP level |
NCT02044302 | A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction | pain | Diazepam (NPC325599) | NP level |
NCT04752033 | Intrathecal Opioids for Colorectal Resection | pain | Morphine (NPC232533) | NP level |
NCT05472259 | A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02044302 | A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction | pain | Morphine (NPC232533) | NP level |
NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00615056 | A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03020030 | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02967289 | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00268372 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00729794 | Vasopressin, Epinephrine, and Steroids for Cardiac Arrest | cardiac arrest | Hydrocortisone (NPC18509) | NP level |
NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02790788 | Physiologic Effects of Steroids in Cardiac Arrest | cardiac arrest | Hydrocortisone (NPC18509) | NP level |
NCT03600623 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002700 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04919226 | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05187520 | Naldebain for Control of Post-Cesarean Section Pain | Chronic pain | Morphine (NPC232533) | NP level |
NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01539538 | A Multicenter, Randomized, Open-Label, Parallel-Group Trial to Compare the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™)to Intravenous Patient-Controlled Analgesia With Morphine for the Treatment of Acute Post-Operative Pain | pain | Morphine (NPC232533) | NP level |
NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03780049 | HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02244632 | Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT03254459 | Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain | pain | Morphine (NPC232533) | NP level |
NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01014364 | Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu | influenza;viral pneumonia | Hydrocortisone (NPC18509) | NP level |
NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03592693 | Vitamin C, Hydrocortisone and Thiamine for Septic Shock | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01071499 | Pharmacokinetics of Oral Morphine and Pharmacogenomics of CYP2D6 and UGT2B7, in an Urban Pediatric Population Presenting for Elective Surgery | pain | Morphine (NPC232533) | NP level |
NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00006472 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02485548 | Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00335816 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | esophageal carcinoma;stomach neoplasm;adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04009759 | Influence of Morphine or Ketamine or Saline Applied During In-hospital Cardiopulmonary Resuscitation on Early Survival | cardiac arrest | Morphine (NPC232533) | NP level |
NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03484299 | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | skin carcinoma;squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03169738 | QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01835262 | Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department | pain | Morphine (NPC232533) | NP level |
NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02212561 | Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic Syndrome | acute lymphoblastic leukemia;myelodysplastic syndrome | Hydrocortisone (NPC18509) | NP level |
NCT00270543 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00672347 | Clonidine and Morphine in Caudal Anesthesia | pain | Morphine (NPC232533) | NP level |
NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01975753 | First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers | pain | Morphine (NPC232533) | NP level |
NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00296608 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04229459 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002793 | Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02483221 | Postoperative Pain Therapy With Hydromorphone TCI-PCA vs. Morphine PCA | pain | Morphine (NPC232533) | NP level |
NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01966172 | Multimodal Analgesic Treatment Versus Traditional Morphine Analgesia After Cardiac Surgery | pain | Morphine (NPC232533) | NP level |
NCT04176952 | PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01354717 | Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | cancer | Fluorouracil (NPC75844) | NP level |
NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | colorectal neoplasm;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05065801 | Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT01941641 | Colon Neoadjuvant FOLFOXIRI Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05186454 | Postoperative Pain Control by Use of Many Drugs in Small Doses Intrathecally | pain | Morphine (NPC232533) | NP level |
NCT04533243 | Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain | cancer | Morphine (NPC232533) | NP level |
NCT03300609 | 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03473093 | Oral Pregabalin Effect to the Intravenous Morphine in Multiple Fracture Ribs | bone fracture | Morphine (NPC232533) | NP level |
NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03085914 | A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03370406 | Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01053039 | The Use of Intrathecal Morphine in the Management of Acute Pain Following Decompressive Lumbar Spinal Surgery | pain | Morphine (NPC232533) | NP level |
NCT03237689 | Effects of Glucocorticoids on Cognition in HIV-infected Women | HIV infection | Hydrocortisone (NPC18509) | NP level |
NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT04437329 | Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03760614 | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02281682 | IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03727061 | Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | head and neck carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02681003 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02459457 | A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00544414 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04589234 | Saltikva for Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02935933 | Paravertebral Morphine Versus Dexmedetomidine on Acute and Chronic Postmastectomy Pain | Chronic pain | Morphine (NPC232533) | NP level |
NCT03649633 | Vitamin C, Steroids, and Thiamine, and Cerebral Autoregulation and Functional Outcome in Septic Shock | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT00463840 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03117595 | CSE for Labour Analgesia: A Comparison of Two Intrathecal Regimens | pain | Morphine (NPC232533) | NP level |
NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00500292 | A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03095222 | Exploring the Safety and Efficacy of Low-dose Ketamine Infusions for Pain Control in Acute Burn Injury | pain | Morphine (NPC232533) | NP level |
NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | cancer | Fluorouracil (NPC75844) | NP level |
NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01526525 | Perioperative Electroacupuncture on Postoperative Analgesia in Prostatectomy | pain | Morphine (NPC232533) | NP level |
NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02646124 | Diazepam Use With Standard Management for Acute Low Back Pain | Low back pain | Diazepam (NPC325599) | NP level |
NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02620631 | Study to Examine Pain Relief With Supplemental Intrathecal Morphine in TKA Patients | pain | Morphine (NPC232533) | NP level |
NCT04495088 | Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02277678 | Comparison of Epidural Oxycodone and Epidural Morphine | Pruritus | Morphine (NPC232533) | NP level |
NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | leukemia;myelodysplastic syndrome;myeloproliferative disorder | Hydrocortisone (NPC18509) | NP level |
NCT00721513 | Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02820857 | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05076838 | Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With Epilepsy | epilepsy | Diazepam (NPC325599) | NP level |
NCT03781323 | Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02023593 | FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02716129 | The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04160520 | Pramipexole and Morphine for Renal Colic | Renal Colic | Morphine (NPC232533) | NP level |
NCT04807972 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | T-cell acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT03472469 | MAST Trial: Multi-modal Analgesic Strategies in Trauma | pain | Morphine (NPC232533) | NP level |
NCT04127019 | Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01830296 | Intravenous Remifentanil Plus Morphine or Morphine Alone for Postthoracotomy Pain | pain | Morphine (NPC232533) | NP level |
NCT02648711 | Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT03165500 | Comparative Evaluation of Three Anxiety Control Protocols in Third Molar Extraction | anxiety | Diazepam (NPC325599) | NP level |
NCT05047991 | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04228601 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00210184 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03428633 | Thoracic Paravertebral Blocks in Open Nephrectomy | pain | Morphine (NPC232533) | NP level |
NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01652976 | Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01691690 | Analgesic Effect of IV Acetaminophen in Tonsillectomies | Recurrent tonsillitis | Morphine (NPC232533) | NP level |
NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01906762 | Comparing the Analgesic Effect of Intravenous Acetaminophen and Morphine on Patients With Renal Colic Pain Reffering to the Emergency Department: A Randomized Controlled Trial | Renal Colic | Morphine (NPC232533) | NP level |
NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02848599 | The Influence of Postoperative Analgesia on Systemic Inflammatory Response and POCD After Femoral Fractures Surgery | post-operative sign or symptom | Morphine (NPC232533) | NP level |
NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01671410 | Buprenorphine for Treatment of Neonatal Abstinence Syndrome in Infants With In Utero Exposure to Benzodiazepines | neonatal abstinence syndrome | Morphine (NPC232533) | NP level |
NCT03534869 | Auricular Acupuncture as Effective Pain Relief After Episiotomy | pain | Diazepam (NPC325599) | NP level |
NCT02264821 | Wound Infusion vs Spinal Morphine for Post-caesarean Analgesia | pain | Morphine (NPC232533) | NP level |
NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Fluorouracil (NPC75844) | NP level |
NCT00460031 | Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT02580253 | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02021422 | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04170530 | Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00383682 | Efficacy of Opioids and Mexiletine for the Treatment of Postamputation Pain | Chronic pain | Morphine (NPC232533) | NP level |
NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00176462 | CINJALL: Treatment for Children With Acute Lymphocytic Leukemia | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00551759 | Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT05493332 | HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003446 | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03817320 | PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00181597 | Trilostane for Androgen-Independent Prostate Cancer | prostate adenocarcinoma | Hydrocortisone (NPC18509) | NP level |
NCT00003994 | Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00002999 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02731430 | Intrathecal Morphine for Postoperative Analgesia Following Laparoscopic Bariatric Surgery | pain | Morphine (NPC232533) | NP level |
NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | cancer | Fluorouracil (NPC75844) | NP level |
NCT03387098 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05171166 | Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02173756 | Evaluation of Oral Morphine Gel in Oral Mucositis Induced by Chemotherapy in Children and Young Adults | cancer | Morphine (NPC232533) | NP level |
NCT01104025 | Hybrid Immunotherapy for Hemophagocytic LymphoHistiocytosis | hemophagocytic syndrome | Hydrocortisone (NPC18509) | NP level |
NCT03371784 | The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER) | myocardial infarction | Hydrocortisone (NPC18509) | NP level |
NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01979354 | 0.15 mg Spinal Morphine vs. no Treatment for Morphine Requirement After VATs. | pain | Morphine (NPC232533) | NP level |
NCT02676349 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00915343 | Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency | adrenocortical insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT02358031 | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02506842 | Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02025023 | Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study | meibomian cyst | Fluorouracil (NPC75844) | NP level |
NCT00454116 | A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00642577 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01566435 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02041481 | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00778102 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | peritoneum cancer | Fluorouracil (NPC75844) | NP level |
NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00142896 | Tramadol to Reduce Opioid Withdrawal Symptoms | opioid dependence | Morphine (NPC232533) | NP level |
NCT01070225 | Reversal of Acute β-Blocker Induced Bronchoconstriction | asthma | Hydrocortisone (NPC18509) | NP level |
NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00103103 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03250832 | Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02375672 | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00080951 | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05338320 | Postoperative Analgesia in Patients Undergoing Elective Lumbar Fusion Operations Under General Anesthesia | pain | Morphine (NPC232533) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003777 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03042780 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | pancreatic endocrine carcinoma;pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00865189 | A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05132504 | Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04181515 | Using rTMS to Explore Neural Mechanisms of Stress-Induced Opioid Use | opioid use disorder | Hydrocortisone (NPC18509) | NP level |
NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006366 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03358472 | Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01079754 | 0.05 Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy | pain | Morphine (NPC232533) | NP level |
NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03189719 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00354107 | Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma | anaplastic large cell lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT03048123 | HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003018 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01704703 | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02804022 | Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia | respiratory depression | Morphine (NPC232533) | NP level |
NCT05139849 | VAsopressin and STeroids in Addition to Adrenaline in Cardiac Arrest - a Randomized Clinical Trial | cardiac arrest | Hydrocortisone (NPC18509) | NP level |
NCT02936934 | Comparison of Adverse Drug Reactions Associated for Oxycodone and Morphine in Postoperative Pain After Abdominal Hysterectomy | pain | Morphine (NPC232533) | NP level |
NCT01802645 | Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01302613 | Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00681174 | Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery | pain | Morphine (NPC232533) | NP level |
NCT02884128 | A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00357149 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01399268 | Steroids in Bilateral Total Knee Replacement | inflammation | Hydrocortisone (NPC18509) | NP level |
NCT01750918 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00066274 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02252926 | Local Anesthetic Treatment of Oral Pain in Patients With Mucositis | mucositis | Morphine (NPC232533) | NP level |
NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03511833 | Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain | injury | Morphine (NPC232533) | NP level |
NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00188877 | Intensity Modulated Radiation Therapy for Head and Neck Cancer | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00316888 | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02817477 | Intranasal Ketamine for Acute Traumatic Pain | pain | Morphine (NPC232533) | NP level |
NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01574014 | Glucocorticoid Treatment for Social Phobia | phobic disorder | Hydrocortisone (NPC18509) | NP level |
NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03487939 | Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02820324 | Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Abdominoplasty | pain | Morphine (NPC232533) | NP level |
NCT02726828 | intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain | pain | Morphine (NPC232533) | NP level |
NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05253846 | Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01452789 | Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome | neonatal abstinence syndrome | Morphine (NPC232533) | NP level |
NCT03869034 | HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01828515 | Vilazodone for Corticosteroid-Induced Memory Impairment | memory impairment | Hydrocortisone (NPC18509) | NP level |
NCT02248493 | Intravenous Paracetamol for Postoperative Pain | pain | Morphine (NPC232533) | NP level |
NCT00000335 | Activity Monitoring Assessment of Opiate Withdrawal - 4 | opioid dependence | Morphine (NPC232533) | NP level |
NCT01896531 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02941562 | A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00563303 | Treatment of Polytraumatisms With Corticoids | injury | Hydrocortisone (NPC18509) | NP level |
NCT00002798 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome | acute erythroleukemia;acute megakaryoblastic leukaemia;acute monocytic leukemia;acute myeloblastic leukemia without maturation;acute myelomonocytic leukemia;chronic myelomonocytic leukemia;refractory anemia;refractory anemia with excess blasts | Hydrocortisone (NPC18509) | NP level |
NCT01844206 | Two Dose Epidural Morphine for Post-cesarean Analgesia | pain | Morphine (NPC232533) | NP level |
NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02302586 | Thoracic Paravertebral Blockade in Video Assisted Thoracoscopic Surgery (VATS) | pain | Morphine (NPC232533) | NP level |
NCT00621478 | Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2) | status epilepticus | Diazepam (NPC325599) | NP level |
NCT04962958 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006051 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04089150 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016198 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03197584 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT00696488 | Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04003792 | Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02969473 | Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Fluorouracil (NPC75844) | NP level |
NCT02142322 | Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04550260 | Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00621985 | Dexamethasone Treatment of Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01081041 | A Study in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03670212 | Investigation of Nicotine Seeking Behavior in Current Smokers | nicotine dependence | Hydrocortisone (NPC18509) | NP level |
NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02101853 | Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01960530 | An Investigational Study of Hydrocortisone | adrenocortical insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02374567 | Pharmacovigilance in Gerontopsychiatric Patients | Dementia;depressive disorder;schizophrenia;anxiety | Diazepam (NPC325599) | NP level |
NCT01136356 | A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals | opioid dependence | Morphine (NPC232533) | NP level |
NCT02602210 | Supplemental Corticosteroids in Cirrhotic Hypotensive Patients With Suspicion of Sepsis | cirrhosis of liver | Hydrocortisone (NPC18509) | NP level |
NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03257319 | Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department | pain | Morphine (NPC232533) | NP level |
NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02279628 | Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03261336 | Oral Calcitriol With Ketoconazole in CRPC | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT02100748 | A Study of TRV130 for the Treatment of Pain After Bunionectomy | pain | Morphine (NPC232533) | NP level |
NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05276323 | Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study | atopic eczema | Hydrocortisone (NPC18509) | NP level |
NCT03037541 | Cryosurgery and Cream Combination for Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02591030 | Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours | bile duct cancer | Fluorouracil (NPC75844) | NP level |
NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03563144 | QUILT-3.088: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00212589 | Patients Preference for Oral or i.v. Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02648425 | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01038609 | Hydrocodone/Acetaminophen for Acute Pain Following Bunionectomy | pain | Morphine (NPC232533) | NP level |
NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | mucinous carcinoma;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04379596 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04356170 | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01871571 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01914900 | Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03580187 | Nebulized Morphine in Chest Trauma Patients: A Prospective Study | injury | Morphine (NPC232533) | NP level |
NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03428360 | Safety and Tolerability Study of Diazepam Buccal Film (DBF) in Subjects With Epilepsy | epilepsy | Diazepam (NPC325599) | NP level |
NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03548246 | Androgen Reduction in Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03383588 | Subcutaneous Bupivacaine Decrease Post-op Pain in Patients Undergoing C-Section | pain | Morphine (NPC232533) | NP level |
NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02115087 | Efficacy Study of Rectus Sheath Block to Control Postoperative Pain | pain | Morphine (NPC232533) | NP level |
NCT03275012 | Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain | Chronic pain | Morphine (NPC232533) | NP level |
NCT01914042 | Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica | neuropathic pain | Morphine (NPC232533) | NP level |
NCT03592992 | Spinal Hydromorphone Versus Morphine for Post-Cesarean Delivery Analgesia | pain | Morphine (NPC232533) | NP level |
NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03092895 | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT03034382 | Morphine and/or Nalbuphine as Adjuvants in Ultrasound Guided Interscalene Block: for Shoulder Surgeries | rotator cuff tear | Morphine (NPC232533) | NP level |
NCT01765582 | Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | anal neoplasm;squamous cell intraepithelial neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03548961 | Organ Preservation in Early Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00494429 | Optimizing the Use of Morphine in Pre-Term Neonates | premature birth | Morphine (NPC232533) | NP level |
NCT05433597 | A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00556413 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01591135 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04793932 | Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01476124 | Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine | restless legs syndrome | Morphine (NPC232533) | NP level |
NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04937738 | Perioperative Chemotherapy in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003436 | Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia | leukemia;myelodysplastic syndrome | Hydrocortisone (NPC18509) | NP level |
NCT04523818 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00005802 | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00004257 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | peritoneal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00217737 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | Lynch syndrome;signet ring cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00499850 | Phase I FOLFOX Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00630032 | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03682393 | Post-operative Corticosteroid Treatment After Mitral Valve Surgery | atrial fibrillation | Hydrocortisone (NPC18509) | NP level |
NCT00813137 | FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02815709 | Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy | pain | Morphine (NPC232533) | NP level |
NCT04887649 | Randomized, Controlled, Double Blind, to Evaluate the Postpartum Analgesia With Epidural Morphine: Analgesic Effect of Two Different Doses Compared to Placebo | pain | Morphine (NPC232533) | NP level |
NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00155233 | Interaction Between Nalbuphine and Morphine in PCA | pain | Morphine (NPC232533) | NP level |
NCT00623766 | Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases | melanoma | Hydrocortisone (NPC18509) | NP level |
NCT03386838 | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00670254 | Hydrocortisone for Prevention of Septic Shock | Sepsis | Hydrocortisone (NPC18509) | NP level |
NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03671252 | Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03774836 | Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty | pain | Morphine (NPC232533) | NP level |
NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Fluorouracil (NPC75844) | NP level |
NCT00609466 | A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy | pain | Morphine (NPC232533) | NP level |
NCT01245244 | Morphine Modulation of The Brain's Pain Matrix | pain | Morphine (NPC232533) | NP level |
NCT03675737 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03953820 | Diazepam Buccal Film (DBF) - Diastat Rectal Gel (DRG) Crossover Study | epilepsy | Diazepam (NPC325599) | NP level |
NCT03585374 | Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA) | injury | Morphine (NPC232533) | NP level |
NCT04510064 | PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02517489 | Community-Acquired Pneumonia : Evaluation of Corticosteroids | pneumonia | Hydrocortisone (NPC18509) | NP level |
NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04151277 | PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03396588 | Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain | neonatal abstinence syndrome | Morphine (NPC232533) | NP level |
NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003063 | Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02410317 | Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03783442 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00237900 | Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02434939 | Low-dose Ketamine vs Morphine for Vaso-occlusive Crisis in Sicklers | pain | Morphine (NPC232533) | NP level |
NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00967616 | Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202774 | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00305058 | Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain | pain | Morphine (NPC232533) | NP level |
NCT03300544 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03404908 | TAP vs QLB in Patients After Cesarean Delivery | pain | Morphine (NPC232533) | NP level |
NCT02246127 | Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02047201 | Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00449137 | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03881111 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02508077 | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02781415 | Acupuncture Versus Titrated Morphine in Patients With Renal Colic | Renal Colic | Morphine (NPC232533) | NP level |
NCT02468557 | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04120701 | CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02885753 | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00625209 | Activated Protein C and Corticosteroids for Human Septic Shock | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03936517 | Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study) | adrenocortical insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00237731 | Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg | pain | Morphine (NPC232533) | NP level |
NCT01047007 | A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02935972 | Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy | pain | Diazepam (NPC325599) | NP level |
NCT03675646 | Spinal Morphine for Postoperative Analgesia in Urology | pain | Morphine (NPC232533) | NP level |
NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003728 | Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01525329 | Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00002883 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01007591 | A Study Comparing LEO 80190 Ointment With Hydrocortisone Ointment, Both Applied Once Daily in the Treatment of Psoriasis Vulgaris on the Face and Intertriginous Areas | psoriasis vulgaris | Hydrocortisone (NPC18509) | NP level |
NCT02534337 | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00558870 | Role of Methadone As Co-Opioid Analgesic | pain | Morphine (NPC232533) | NP level |
NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | laryngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00805285 | The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis | ulcerative colitis | Hydrocortisone (NPC18509) | NP level |
NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01417078 | A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode | epilepsy | Diazepam (NPC325599) | NP level |
NCT01094522 | Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery. | pain | Morphine (NPC232533) | NP level |
NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00326612 | Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures | Seizure | Diazepam (NPC325599) | NP level |
NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04354662 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02024607 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | cancer | Fluorouracil (NPC75844) | NP level |
NCT00528177 | Morphine vs. Oxycodone for Postoperative Pain Management | pain | Morphine (NPC232533) | NP level |
NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03017248 | Low-dose Ketamine for Acute Pain in the Emergency Department | pain | Morphine (NPC232533) | NP level |
NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01918917 | Adding Intra-articular Dexmedetomidine to Levobupivacaine for Postoperative Analgesia in Arthroscopic Knee Surgery | pain | Morphine (NPC232533) | NP level |
NCT00665392 | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03120403 | Safety and Efficacy of Intrathecal Morphine in Children | cancer | Morphine (NPC232533) | NP level |
NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02672917 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00992199 | Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02848729 | Drug Interactions Between Morphine and Orally or IV Administered Acetaminophen | pain | Morphine (NPC232533) | NP level |
NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02473263 | Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock | Sepsis | Hydrocortisone (NPC18509) | NP level |
NCT03504423 | Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02714543 | Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study | oral submucous fibrosis | Hydrocortisone (NPC18509) | NP level |
NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04348305 | Hydrocortisone for COVID-19 and Severe Hypoxia | COVID-19;hypoxia | Hydrocortisone (NPC18509) | NP level |
NCT03197571 | QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | urothelial carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00571740 | Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02043587 | Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma | acute lymphoblastic leukemia;lymphoblastic lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04755543 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03168607 | Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01735617 | Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01490866 | A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03340896 | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00436267 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05052099 | Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01933542 | The Effect of Chlorzoxazone on Moderate to Severe Postoperative Pain After Spine Surgery | pain | Morphine (NPC232533) | NP level |
NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03035578 | Development of a Morphine Pharmacokinetic and Pharmacodynamic Model for the Neonatal Population | pain | Morphine (NPC232533) | NP level |
NCT02715531 | A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00803114 | Epidural Morphine Following Vaginal Delivery | pain | Morphine (NPC232533) | NP level |
NCT01142414 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT02071069 | Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00704262 | Effect of Calcipotriol Plus Hydrocortisone Ointment on the Adrenal Hormone Balance and Calcium Metabolism in Patients With Psoriasis Vulgaris on the Face and Skin Folds | psoriasis vulgaris | Hydrocortisone (NPC18509) | NP level |
NCT00719199 | Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02319304 | Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02145975 | Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine | pain | Morphine (NPC232533) | NP level |
NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01374425 | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484221 | Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05251038 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01013805 | Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01953406 | The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02735707 | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia | COVID-19;influenza;pneumonia | Hydrocortisone (NPC18509) | NP level |
NCT00001521 | Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01348217 | Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00747799 | Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02967887 | Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00618501 | Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT03007121 | Intrathecal Morphine Analgesia vs. Continuous Epidural Analgesia vs. Systemic Analgesia in Colorectal Surgery. | pain | Morphine (NPC232533) | NP level |
NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04217954 | HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00873093 | Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | B-cell acute lymphoblastic leukemia;lymphoblastic lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00309894 | Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | chronic myeloproliferative disorder;multiple myeloma;myelodysplastic syndrome | Fluorouracil (NPC75844) | NP level |
NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01866254 | Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries | pain | Morphine (NPC232533) | NP level |
NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03063359 | Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma | pain | Morphine (NPC232533) | NP level |
NCT03236805 | Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia | pain | Morphine (NPC232533) | NP level |
NCT03134703 | Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome | neonatal abstinence syndrome | Morphine (NPC232533) | NP level |
NCT05221658 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04949256 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006115 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03825887 | Nalbuphine Versus Morphine for Mucositis Pain in Pediatric Cancer Patients | acute myeloid leukemia | Morphine (NPC232533) | NP level |
NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02810782 | How to Treat Opiate Withdrawal in Neonates | neonatal abstinence syndrome | Morphine (NPC232533) | NP level |
NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00940303 | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03110926 | Induction Chemotherapy for Locally Advanced Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03224039 | Intranasal Sufentanil Versus Intravenous Morphine for the Management of Acute Pain | pain | Morphine (NPC232533) | NP level |
NCT02973685 | HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04469556 | Pancreatic Adenocarcinoma Signature Stratification for Treatment | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00083109 | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | renal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03179891 | Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy | epilepsy | Diazepam (NPC325599) | NP level |
NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002893 | Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04839731 | Combination 5-FU / Calcipotriene Cream for SCCIS/SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002498 | Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03605706 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05179889 | Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04369950 | Post-cesarean Analgesia With Epidural Morphine Following Epidural 2-chloroprocaine | pain | Morphine (NPC232533) | NP level |
NCT02622126 | Colloid Pre-Loading on D-Dimer During Cesarean Section Under Spinal Anesthesia | blood coagulation disease;hemorrhage | Morphine (NPC232533) | NP level |
NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01489865 | ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05229497 | FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC | cancer | Fluorouracil (NPC75844) | NP level |
NCT05078827 | Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | anal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00392834 | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma | lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00634010 | Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain | cancer | Morphine (NPC232533) | NP level |
NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04898894 | Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia | acute leukemia of ambiguous lineage | Hydrocortisone (NPC18509) | NP level |
NCT00497497 | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03861702 | Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00220454 | Effect of Estrogen & Stress for Postmenopausal Women | aging | Hydrocortisone (NPC18509) | NP level |
NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01522989 | PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01633970 | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT02456142 | CAUDAL BUPIVACAINE VERSUS INTRAVENOUS MORPHINE ON TIME TO FIRST ANALGESIC REQUIREMENT | pain | Morphine (NPC232533) | NP level |
NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112697 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02852382 | The Effects of Scalp Block on Haemodynamic Response and Postoperative Pain in Posterior Fossa Surgery | neoplasm | Morphine (NPC232533) | NP level |
NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04854499 | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05015621 | A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05332002 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03991962 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Fluorouracil (NPC75844) | NP level |
NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02868944 | Interest of the Injection of Morphine, in Addition to a Local Anesthetic When Performing a Combined Spinal-epidural for Labor Analgesia | pregnancy | Morphine (NPC232533) | NP level |
NCT05476432 | HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03487016 | First-line Therapy in Metastatic PDAC | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00069121 | A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02954484 | Outcomes Of Perioperative Pregabalin On Total Knee Arthroplasty | pain | Morphine (NPC232533) | NP level |
NCT01364558 | A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers | epilepsy | Diazepam (NPC325599) | NP level |
NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03062280 | A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT01186445 | Morphine In Acute Myocardial Infarction | acute myocardial infarction | Morphine (NPC232533) | NP level |
NCT00803283 | A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain | cancer | Morphine (NPC232533) | NP level |
NCT05361447 | Diazepam Trial in GAD65 Associated Epilepsy | epilepsy | Diazepam (NPC325599) | NP level |
NCT02289768 | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT03484195 | Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT05166772 | Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)in the First-line Treatment of Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002881 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT01465191 | Effect of Mu-opioid Receptor Genetics on 3 Doses of Spinal Morphine for Postoperative Analgesia After Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01938092 | Vaginal Diazepam for the Treatment of Female Pelvic Pain | pain | Diazepam (NPC325599) | NP level |
NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02405585 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT03036384 | Estimation of the ED95 of Intrathecal Hyperbaric Prilocaine 2% With Sufentanyl for Scheduled Cesarean Delivery | pregnancy | Morphine (NPC232533) | NP level |
NCT03577704 | The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00098787 | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004297 | Phase III Randomized Study of Diazepam Vs Lorazepam Vs Placebo for Prehospital Treatment of Status Epilepticus | status epilepticus | Diazepam (NPC325599) | NP level |
NCT00784472 | Visceral Pain From the Upper Urinary Tract - a Trial on the Effect of Morphine and Oxycodone in Patients Undergoing PCNL | nephrolithiasis | Morphine (NPC232533) | NP level |
NCT01181401 | InductionChemo-Radio-Antibody-Treatment | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03421353 | AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05239741 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01332604 | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00980876 | A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension | otitis externa | Hydrocortisone (NPC18509) | NP level |
NCT00008060 | Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002692 | Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02017600 | A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02921256 | Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00236925 | Efficacy Study of Low-Dose Hydrocortisone Treatment for Fibromyalgia | fibromyalgia | Hydrocortisone (NPC18509) | NP level |
NCT01084161 | Study to Evaluate the Efficacy, Safety and Tolerability of N1539 | pain | Morphine (NPC232533) | NP level |
NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00131053 | Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02535806 | Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults | acute lymphoblastic leukemia;lymphoblastic lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT03443661 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00482053 | Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | diffuse large B-cell lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00002855 | Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03843281 | Efficacy of Paracetamol in Addition to Morphine to Improve Analgesia in the Emergency Department | pain | Morphine (NPC232533) | NP level |
NCT00755989 | Use of Morphine Gel Topically in Patients With Stage 2-3 Wounds | injury | Morphine (NPC232533) | NP level |
NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00261703 | Docetaxel in Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00208936 | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT02817113 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03872011 | Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT01951963 | Sub-dissociative Ketamine for the Management of Acute Pediatric Pain | pain | Morphine (NPC232533) | NP level |
NCT00081289 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00498953 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04185883 | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02425852 | A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis | ulcerative colitis | Hydrocortisone (NPC18509) | NP level |
NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00995293 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01304134 | Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment | pain | Morphine (NPC232533) | NP level |
NCT02465606 | A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis | atopic eczema | Hydrocortisone (NPC18509) | NP level |
NCT02111746 | PAIN - Postoperative Analgesia INvestigation | pain | Morphine (NPC232533) | NP level |
NCT02673372 | Geriatric Ketamine for Pain Management Study | pain | Morphine (NPC232533) | NP level |
NCT01941589 | Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis | ulcerative colitis | Hydrocortisone (NPC18509) | NP level |
NCT00201539 | Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients | cancer | Morphine (NPC232533) | NP level |
NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02830139 | Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT02400567 | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00963729 | Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00142519 | Comparison of A Single Dose Combination of Methadone and Morphine With Morphine Alone for Treating Post-operative Pain | pain | Morphine (NPC232533) | NP level |
NCT03764553 | Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02096003 | Intrathecal Hydromorphone for Pain Control After Cesarean Section | pain | Morphine (NPC232533) | NP level |
NCT04794738 | A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery | pain | Morphine (NPC232533) | NP level |
NCT00592501 | Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04481204 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05160506 | Corticosteroids to Treat Pancreatitis | pancreatitis | Hydrocortisone (NPC18509) | NP level |
NCT01123551 | Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain | injury | Morphine (NPC232533) | NP level |
NCT05024097 | A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02842580 | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04480190 | Neoadjuvant Therapy in Biliary Adenocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00468169 | Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05466799 | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03913559 | Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05083247 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03730714 | Surgicel and Analgesic Reservoir | pain | Morphine (NPC232533) | NP level |
NCT04927780 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003298 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03574649 | QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01080911 | 0.05 mg Versus 0.1 mg Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy | pain | Morphine (NPC232533) | NP level |
NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01836653 | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387085 | QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01217060 | Trimodality Management of T1b Esophageal Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01790555 | Perioperative Δ9-THC for Postsurgical Pain | pain | Diazepam (NPC325599) | NP level |
NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00982891 | Palliation of Dyspnea in Advanced Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Morphine (NPC232533) | NP level |
NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT02316847 | An Open-Label, Safety and Tolerability Study of Chronic Intermittent Use of Diazepam Nasal Spray. | epilepsy | Diazepam (NPC325599) | NP level |
NCT00954512 | Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002805 | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02698995 | Perineural Low-dose Dexamethasone Added to Infraclavicular Block Anesthesia | pain | Morphine (NPC232533) | NP level |
NCT05033522 | Immunotherapy for Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01099358 | Study in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01675622 | Immediate-Release Oxycodone Capsules Study in Cancer Pain | cancer | Morphine (NPC232533) | NP level |
NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | thrombotic disease;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00953576 | Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03639389 | Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy | pain | Morphine (NPC232533) | NP level |
NCT00423696 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002525 | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004034 | Treatment of Childhood Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT04994236 | Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02482441 | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00166465 | Stage IV Colorectal CA ALIMTA | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04231708 | Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder | opioid use disorder | Hydrocortisone (NPC18509) | NP level |
NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | esophageal carcinoma;stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00859781 | 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03825198 | Lumbar Erector Spinae Plane Block for Back Surgery | Back pain | Morphine (NPC232533) | NP level |
NCT01063569 | Glucocorticoid Treatment in Addison's Disease | chronic primary adrenal insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT00460239 | Buprenorphine's Dose Response Curve | opioid dependence | Morphine (NPC232533) | NP level |
NCT01265017 | Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes | type 1 diabetes mellitus | Hydrocortisone (NPC18509) | NP level |
NCT00705822 | Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer | prostate adenocarcinoma | Hydrocortisone (NPC18509) | NP level |
NCT00390039 | Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery | pain | Morphine (NPC232533) | NP level |
NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01036594 | Ketoconazole and Dexamethasone in Prostate Cancer | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00413322 | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma;metastasis | Fluorouracil (NPC75844) | NP level |
NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03639389 | Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy | pain | Diazepam (NPC325599) | NP level |
NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00136435 | A Study in Adults With Untreated Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00006786 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04921189 | Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors | cardiac arrest | Hydrocortisone (NPC18509) | NP level |
NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00005979 | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00478946 | A Study of Picoplatin in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01528618 | Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01860664 | Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis | allergic conjunctivitis | Hydrocortisone (NPC18509) | NP level |
NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | dysplasia of cervix | Fluorouracil (NPC75844) | NP level |
NCT02383966 | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT04448561 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASP8062 With a Single Dose of Morphine in Recreational Opioid Using Participants | opioid use disorder | Morphine (NPC232533) | NP level |
NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01771328 | Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT01953978 | The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery | pain | Morphine (NPC232533) | NP level |
NCT01309386 | A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants | neoplasm | Morphine (NPC232533) | NP level |
NCT02300194 | Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures | pain | Morphine (NPC232533) | NP level |
NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00213200 | Intravenous and Topical Analgesics for Procedural Pain in Neonates | pain | Morphine (NPC232533) | NP level |
NCT00006468 | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02177955 | Comparative Study of Hemodynamic Changes Caused by Diazepam and Midazolam During Third Molar Surgery | anxiety | Diazepam (NPC325599) | NP level |
NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00375713 | Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema | dermatitis;Eczema | Hydrocortisone (NPC18509) | NP level |
NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01522534 | Randomized Double Blind Controlled Trial Comparing a Blind Sciatic Nerve Block in the Popliteal Fossa to Intravenous Morphine for Traumatic Severe Acute Pain in the Prehospital Setting | pain | Morphine (NPC232533) | NP level |
NCT03222349 | Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy | epilepsy | Diazepam (NPC325599) | NP level |
NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01718496 | Morphine, Dyspnea, Exercise and COPD | chronic obstructive pulmonary disease | Morphine (NPC232533) | NP level |
NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00186628 | Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD | mast-cell leukemia | Hydrocortisone (NPC18509) | NP level |
NCT03368859 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | cancer | Fluorouracil (NPC75844) | NP level |
NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | uterine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02937116 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01542931 | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00807911 | Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03443492 | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02095366 | Intra Nasal Sufentanil Versus Intravenous Morphine for Acute Severe Traumatic Pain Analgesia in Emergency Setting | pain | Morphine (NPC232533) | NP level |
NCT00023868 | Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02687347 | Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain | pain | Morphine (NPC232533) | NP level |
NCT05135364 | HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00324415 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02724423 | Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects | Seizure | Diazepam (NPC325599) | NP level |
NCT05024513 | Biliary Drainage Plus HAIC in Locally Advanced pCCA | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03175666 | QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00797485 | Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02435537 | Combined Intrathecal Morphine and Dexmedetomidine Analgesia | pain | Morphine (NPC232533) | NP level |
NCT04243954 | Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration | cancer | Morphine (NPC232533) | NP level |
NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT02078089 | Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain | cancer | Morphine (NPC232533) | NP level |
NCT02268695 | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | esophageal carcinoma;gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03818932 | Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction | injury | Diazepam (NPC325599) | NP level |
NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | cancer | Fluorouracil (NPC75844) | NP level |
NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00526110 | Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01718964 | Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) | opioid dependence | Hydrocortisone (NPC18509) | NP level |
NCT01383707 | A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01333709 | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002756 | Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT02795988 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03136406 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00478023 | A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy | pain | Morphine (NPC232533) | NP level |
NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01167725 | Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03648008 | Postoperative Analgesic Effect of Hydromorphone on Partial Pulmonary Resection Under Video-assisted Thoracoscopy | pain | Morphine (NPC232533) | NP level |
NCT01324141 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01472016 | Study of ABT-700 in Subjects With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02225652 | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00303771 | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | biliary tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00015886 | Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04325425 | Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002704 | Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01837446 | Morphine Mouthwash for Management of Oral Mucositis in Patients With Head and Neck Cancer | stomatitis | Morphine (NPC232533) | NP level |
NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05268510 | Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03722498 | Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02640365 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003422 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01574612 | Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old | Herpes Labialis | Hydrocortisone (NPC18509) | NP level |
NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01274962 | A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01442649 | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00390312 | Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction | pain | Morphine (NPC232533) | NP level |
NCT01867294 | Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab | cancer | Hydrocortisone (NPC18509) | NP level |
NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00062426 | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04393298 | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05218733 | Ultrasound Guided Erector Spinae Plane Block vs Intrathecal Morphine | pain | Morphine (NPC232533) | NP level |
NCT00002896 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03109158 | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01825993 | RANDOMISED STUDY OF EPIDURAL VS MPCA MORPHINE VS TAPP IN LAPAROSCOPIC SIGMOIDECTOMY | neoplasm | Morphine (NPC232533) | NP level |
NCT00525759 | Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03019614 | An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone | congenital adrenal hyperplasia | Hydrocortisone (NPC18509) | NP level |
NCT02677532 | Epidural Versus Wound Infusion Plus Morphine Bolus in Open Abdominal Aortic Aneurysm Repair | pain | Morphine (NPC232533) | NP level |
NCT03329248 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00628810 | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04852003 | A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal | pain | Morphine (NPC232533) | NP level |
NCT04849455 | Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection | pain | Morphine (NPC232533) | NP level |
NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02241551 | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03023982 | Pectoralis and Serratus Nerves Block in Thoracic Surgery | injury | Morphine (NPC232533) | NP level |
NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02141295 | A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations | acute myeloid leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01882530 | Non-opioid Analgesic Combination With Morphine for Postoperative Analgesia. | pain | Morphine (NPC232533) | NP level |
NCT02291289 | A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00278694 | Oxaliplatin and 5-FU Based Preoperative Chemoradiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02511483 | Genetic Predictors of Analgesic Efficacy of Propranolol for Treating Postoperative Pain | pain | Morphine (NPC232533) | NP level |
NCT00136682 | Patient-Controlled Epidural Analgesia (PCEA) for Patients Who Have Had Major Open Gynecologic Surgery | pain | Morphine (NPC232533) | NP level |
NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05217069 | A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT04390399 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00274937 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01304212 | Effectiveness of Analgesia in Total Knee Arthroplasty | pain | Morphine (NPC232533) | NP level |
NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;renal cell carcinoma;non-small cell lung carcinoma;ovarian carcinoma;breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00820027 | Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) | pain | Morphine (NPC232533) | NP level |
NCT03748134 | Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01821729 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05214339 | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003260 | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00676585 | Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest | cardiac arrest | Hydrocortisone (NPC18509) | NP level |
NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002888 | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04221165 | Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer | head and neck malignant neoplasia | Morphine (NPC232533) | NP level |
NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT03579446 | Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | pain | Morphine (NPC232533) | NP level |
NCT00349401 | Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation | pain | Morphine (NPC232533) | NP level |
NCT00264485 | A Comparison of the Safety and Effectiveness of Two Forms of Patient-controlled Pain Medication Used After Total Hip Replacement: The E-TRANS Fentanyl Transdermal System Versus the Morphine Intravenous Pump | pain | Morphine (NPC232533) | NP level |
NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00541112 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01289821 | First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03333278 | The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial | Sepsis;septic shock | Hydrocortisone (NPC18509) | NP level |
NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01126216 | Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00623740 | PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates | bronchopulmonary dysplasia | Hydrocortisone (NPC18509) | NP level |
NCT03968146 | Erector Spinae Plane Block in Scoliotic Adolescents | scoliosis | Morphine (NPC232533) | NP level |
NCT00195910 | Safety and Efficacy Study of Hydromorphone and Morphine | pain | Morphine (NPC232533) | NP level |
NCT02720068 | Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03067792 | FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03082209 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT02976597 | Ultrasound Guided TAP Block for Postoperative Analgesia After Abdominal Surgery. | pain | Morphine (NPC232533) | NP level |
NCT02270788 | Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies | acute myeloid leukemia | Hydrocortisone (NPC18509) | NP level |
NCT04420884 | A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04523935 | Excessive Crying in Children With Cerebral Palsy and Communication Deficits | cerebral palsy | Diazepam (NPC325599) | NP level |
NCT00346268 | Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy | pain | Morphine (NPC232533) | NP level |
NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00133991 | Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia | leukemia;lymphoma | Hydrocortisone (NPC18509) | NP level |
NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01362374 | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02303821 | Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT05314998 | Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01186328 | EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | acute lymphoblastic leukemia | Hydrocortisone (NPC18509) | NP level |
NCT00999700 | Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03143153 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04675983 | A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03130790 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04722133 | Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00996177 | A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously | pain | Morphine (NPC232533) | NP level |
NCT00895310 | Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy | prostate cancer | Hydrocortisone (NPC18509) | NP level |
NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00611507 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03524508 | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00467142 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01367418 | Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy | prostate cancer | Morphine (NPC232533) | NP level |
NCT02028806 | mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | Central Nervous System Neoplasm | Hydrocortisone (NPC18509) | NP level |
NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03151863 | Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care | pain | Morphine (NPC232533) | NP level |
NCT00265811 | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00070213 | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03607916 | Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery. | pregnancy | Morphine (NPC232533) | NP level |
NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00244153 | Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis | rheumatic disease | Morphine (NPC232533) | NP level |
NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00287326 | Comparison of Low-dose Epidural With Intravenous Narcotic Versus Intravenous Narcotic Alone | pain | Morphine (NPC232533) | NP level |
NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | laryngeal neoplasm;oral cavity cancer;paranasal sinus neoplasm;pharynx cancer | Fluorouracil (NPC75844) | NP level |
NCT03169764 | QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03948464 | Slow-Release Oral Morphine for the Treatment of Opioid Use Disorder | opioid dependence | Morphine (NPC232533) | NP level |
NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01847690 | Effect of Cortisol on Physical Exertion in Patients With Primary Adrenal Failure | chronic primary adrenal insufficiency | Hydrocortisone (NPC18509) | NP level |
NCT03005548 | Cortical Modulation of Acute Post-thoracotomy Pain With Transcranial Direct Current Stimulation | pain | Morphine (NPC232533) | NP level |
NCT01269229 | A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02393833 | IBCSG Trial 22-00 Serum Substudy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00320099 | Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock | septic shock | Hydrocortisone (NPC18509) | NP level |
NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03238430 | Management of Pain Post Hepatectomy : Infiltration of Local Anesthetics Versus Continuous Spinal Analgesia . | pain | Morphine (NPC232533) | NP level |
NCT03068260 | Ultrasound-guided Transmuscular Quadratus Lumborum Block for Elective Caesarean Section. | pain | Morphine (NPC232533) | NP level |
NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01418222 | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03088306 | Improving Pain and Reducing Opioid Use (IPaRO) in Lumbar Spine Surgery Patients | pain | Diazepam (NPC325599) | NP level |
NCT04488159 | Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT03012971 | Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery | pain | Morphine (NPC232533) | NP level |
NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00384878 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02440958 | Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03678792 | Comparison of Three Opioid Detoxification Treatment Regimens | opioid dependence | Morphine (NPC232533) | NP level |
NCT03537612 | Sensorial and Physiological Mechanism-based Assessments of Perioperative Pain | scoliosis | Morphine (NPC232533) | NP level |
NCT00091312 | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00983541 | Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | cancer | Fluorouracil (NPC75844) | NP level |
NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01787006 | Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05235542 | A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04188418 | Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients | shortness of breath | Morphine (NPC232533) | NP level |
NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03015246 | Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence | heroin dependence;opioid use disorder | Morphine (NPC232533) | NP level |
NCT03326947 | Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002865 | High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia | leukemia | Hydrocortisone (NPC18509) | NP level |
NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | bladder tumor | Fluorouracil (NPC75844) | NP level |
NCT00385541 | Comparison of Side Effects of Morphine and Hydromorphone Patient-Controlled Analgesia (PCA) | pain | Morphine (NPC232533) | NP level |
NCT02462577 | Effect of Locally Administered Morphine and Bupivicaine on Acute and Chronic Postmastectomy Pain | Chronic pain | Morphine (NPC232533) | NP level |
NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05319639 | Phase I Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT02217020 | Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02912195 | Intravenous Lidocaine Versus Morphine for Severe Pain in the ED | pain | Morphine (NPC232533) | NP level |
NCT02196142 | Acute Effects of Cortisol on Alcohol Craving in Alcohol Dependence | alcohol dependence | Hydrocortisone (NPC18509) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
CXCL8,GABRG2,GABRA2
NCT02114359,NCT01774786,NCT01662869,NCT01896531,NCT01286766,NCT03694522,NCT02563054,NCT03825861,NCT02142322,NCT01924819,NCT01283204,NCT01285557,NCT00020787,NCT04859582,NCT00976768,NCT00002883,NCT00992199,NCT04358341,NCT00003172,NCT03607656,NCT03675737,NCT00711243,NCT01851941,NCT00142350,NCT00270543,NCT00188266,NCT00210184,NCT00400179,NCT04155671,NCT00149201,NCT00103103,NCT01041404,NCT00313872,NCT01769508,NCT00525785,NCT04757363,NCT01889303,NCT00811447,NCT04997837,NCT00202969,NCT03015675,NCT00447967,NCT00215514,NCT00002722,NCT02296671,NCT00004873,NCT00611507,NCT01503372,NCT00595972,NCT01183559,NCT00374036,NCT00857246,NCT05319639,NCT04358354,NCT01198392,NCT00941655,NCT02442362,NCT04379596,NCT03067792,NCT02845908,NCT04149015,NCT04393584,NCT00003862,NCT00514020,NCT00555672,NCT00123318,NCT04354662,NCT03130790,NCT03606928,NCT00004233,NCT02486601,NCT00003298,NCT00384878,NCT00052910,NCT00005060,NCT00155883,NCT02934464,NCT01590719,NCT02578368,NCT00002615,NCT04937738,NCT02574663,NCT01216644,NCT00343239,NCT00054873,NCT00004099,NCT03939962,NCT00002783 |
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT02641691,NCT04703101,NCT01333709,NCT00068692,NCT01383343,NCT02000050,NCT04749108,NCT00308516,NCT01804790
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
GABRG2,GABRA3,OPRD1,OPRK1,TBXAS1,MMP9,TSHR,GABRA5,CXCL8
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
GABRG2,GABRA3,OPRD1,OPRK1,THPO,MMP9,AKR1C3,TSHR,GABRA5
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GABRG2,GABRA3,GABRA1,NFKB1,OPRK1,TBXAS1,PTGDR2,MMP9,GABRA5
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
PGR,CXCL8,NFKB1,MMP9,HIF1A,NR3C1,PTGS1,PTGS2
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
PTGS1,NR3C1,NFKB1,NR3C1,PTGS2
NCT02465606,NCT00375713,NCT05276323 |
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
NCT00563303,NCT03511833,NCT03580187,NCT00755989,NCT01123551,NCT03818932,NCT03585374,NCT03023982
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
GABRA1,OPRD1,OPRK1,THPO,GLI1,PGR,MMP9,CXCL8
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
GABRG2,GABRA3,OPRD1,THPO,SERPINA6,MMP9,GABRA5,GABRA1
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AR,NFKB1
NCT03825887,NCT00002798,NCT03071276,NCT04293562,NCT02270788 |
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT00065117,NCT02124148,NCT00126256,NCT00149201,NCT02419495,NCT00289445,NCT00374036
|
Septic shockDisease Category: X.Extension CodesDisease ICD-11 Code: XS26 |
NCT03710187,NCT00625209,NCT03872011,NCT00320099,NCT03592693,NCT03333278,NCT03649633
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
OPRD1,MMP9,CXCL8,OPRD1,TBXAS1,MMP9,TSHR
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
GABRG2,GABRA3,OPRK1,MMP9,AKR1C3,TSHR,GABRA5
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
PTGS2,PTGS1,TBXAS1,LMNA,AR,CXCL8,TSHR
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
NCT00416858,NCT00544362,NCT00393068,NCT00259402,NCT00193882,NCT00735345,NCT00209690,NCT01348217,NCT00020787,NCT03110926,NCT00209716,NCT01372202,NCT00551759,NCT00004897,NCT00041262,NCT01787006,NCT00008047,NCT01843049,NCT01217060,NCT00002631,NCT00525915,NCT00759226,NCT03002064,NCT00425425,NCT00230451,NCT03189719,NCT01608464,NCT00002884,NCT00003118,NCT00381706,NCT00052910,NCT00539617,NCT03764553,NCT00047112,NCT03279237,NCT00002984,NCT01704690,NCT00733889,NCT03281369,NCT00570531,NCT00069953,NCT03881111,NCT00915850,NCT00075738,NCT00004233,NCT00002897,NCT00086996,NCT01998347,NCT00193141,NCT02359968,NCT00004257,NCT00160030,NCT02574663,NCT03910634,NCT00632333,NCT00861094,NCT00002883,NCT01183559,NCT00054873,NCT00021320,NCT02735239,NCT00258323,NCT00006472,NCT02023593,NCT01611857
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT00021073,NCT00005791,NCT00004913,NCT00838370,NCT01946074,NCT00080990,NCT00005068,NCT02482441,NCT00995293,NCT00954512,NCT02720068,NCT02817113,NCT01309386,NCT01362374,NCT01472016,NCT02884128,NCT00024141,NCT00020488,NCT00042861,NCT02588105,NCT00357149,NCT02852382,NCT00261703,NCT04420884,NCT04176952,NCT02648711,NCT00043121,NCT00289445,NCT02723955,NCT04047862,NCT01930552,NCT04541108,NCT00007878,NCT03577704,NCT02648425,NCT00004059,NCT03503604,NCT00448136,NCT01825993,NCT00042874,NCT01206465,NCT01099358,NCT04185883,NCT00811993,NCT03326947,NCT03421353,NCT00402545,NCT00413322,NCT02715531,NCT01522989,NCT00044785,NCT01634555,NCT00502567,NCT00610948,NCT04393298,NCT01566435,NCT00004242,NCT04607421,NCT03250832,NCT03085914,NCT00246103,NCT04151277,NCT00215501,NCT01047007
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
SERPINA6,PTGDR2,NR3C1,TBXAS1,PTGS2
NCT01070225 |
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
PTGS1,NR3C2,NFKB1,TBXAS1,NR3C1,PTGS2
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
OPRD1,NFKB1,PTGS1,MMP9,NR3C1,PTGS2
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
NFKB1
CXCL8 NCT00640822,NCT00704262,NCT01007591,NCT00691002 |
Adrenocortical insufficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A74 |
NR3C2
NCT03936517,NCT01960530,NCT05222152,NCT00915343,NCT01450930 |
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
GABRA1,GABRA3,OPRD1
NCT03165500,NCT02374567,NCT02177955 |
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00024349,NCT00055601,NCT00981656,NCT00003175,NCT00003642,NCT00006111
|
Cardiac arrestDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MC82 |
NCT02790788,NCT00676585,NCT04009759,NCT00729794,NCT04921189,NCT05139849
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
PTGS1,GLI1,HIF1A,MMP9,LMNA,CXCL8
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT00093665,NCT00003576,NCT02741570,NCT00665392,NCT00122460,NCT00002735,NCT00113399,NCT00006248,NCT00006051,NCT00004089,NCT00095875,NCT00203905,NCT00646659,NCT00004164,NCT00002839,NCT04356170,NCT04428333,NCT00268372,NCT00004901,NCT00003637,NCT00003627,NCT01142414,NCT00460265,NCT00868491,NCT02353260,NCT01081041,NCT00004094,NCT00003777,NCT02997332,NCT00608205,NCT00193284,NCT00052429,NCT00054054,NCT01126216,NCT00002496,NCT01911598,NCT00004097,NCT00002999,NCT00004865,NCT03358472,NCT00002476,NCT00392704,NCT02358031,NCT00468169,NCT00002888,NCT03342352,NCT00498953,NCT00002747,NCT00352105,NCT03727061,NCT00544414,NCT01467115,NCT04221165,NCT00352118,NCT03386838,NCT00003888,NCT00721513
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT02527772,NCT04962958,NCT00921531,NCT00471965,NCT00143403,NCT00559455,NCT03468231,NCT05214339,NCT03563170,NCT05029973,NCT05166772,NCT03048123,NCT02767375,NCT05476432,NCT01327521,NCT02426450,NCT03605706,NCT02774187,NCT02452853,NCT02755311,NCT03869034,NCT03192644,NCT05135364,NCT04994236,NCT03780049,NCT03812783,NCT03722498,NCT03192618,NCT00619541,NCT01171482,NCT00849264,NCT03812770,NCT05263219,NCT05033522,NCT02967887,NCT01055743,NCT03469479,NCT03803254,NCT03780634,NCT02580253,NCT05493332,NCT00933816,NCT01775501,NCT02973685,NCT01953406,NCT05171166,NCT02981498,NCT02069041,NCT02534337,NCT02987699
|
Female pelvic painDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA34 |
PGR,PTGS1,PTGS2,AKR1C3,AR
|
Spinal painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84 |
OPRM1,OPRD1,PTGS2,PTGS1
NCT03825198 |
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
MMP9,PTGS1
NCT02425852,NCT01941589,NCT00805285 |
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
AR,PTGDR2,NR3C1
NCT01718496,NCT00982891 |
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
OPRM1,ADRA2A,NR3C1,OPRK1,GABRA1
|
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT01413022,NCT00220649,NCT01121848,NCT05083247,NCT00417209
|
Malignant neoplasms of stomach, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.Z |
NCT02048540,NCT00237900,NCT03081143,NCT00509964,NCT01748851
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT01779050,NCT00429299,NCT01220128,NCT00174707,NCT00121992
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT05348811,NCT04480190,NCT02456714,NCT03603834,NCT05024513
|
SepsisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1G40-1G41 |
NCT02473263,NCT00670254,NCT00732277,NCT03333278,NCT03509350
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
NCT00238160,NCT00507585,NCT03092895,NCT00471484,NCT03164382
|
Precursor B-lymphoblastic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A70 |
NCT02535806,NCT02043587,NCT00873093,NCT01451515,NCT03817320
|
Neonatal withdrawal syndrome from maternal use of drugs of addictionDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KD35 |
NCT02810782,NCT03396588,NCT01671410,NCT03134703,NCT01452789
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
SMN1,THPO,AR,TSHR,LMNA
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
GABRG2,GABRB1,GABRB3,GABRA2,GABRA5
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
GABRA3,NR3C1,AR,MMP9,GABRA5
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
OPRD1,OPRK1,NFKB1,OPRM1
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
AR,PTGS2,NR3C2,PTGS1
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
PTGS1,NR3C1,PTGS2,SERPINA6
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
PTGS1,NR3C1,NFKB1,AR
|
PruritusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EC90 |
OPRM1,OPRK1
NCT02277678,NCT01071057 |
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
OPRM1,NR3C1,OPRK1,ADRA2A
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO,PTGS1,PTGS2
NCT03371784 |
MigraineDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A80 |
PTGS2,OPRD1,OPRM1,PTGS1
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
CXCL8
NCT04348305,NCT04359511,NCT02735707 |
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
MMP9
MMP9,PTGS2,CXCL8 |
Renal colicDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF56 |
NCT02781415,NCT04160520,NCT01906762,NCT02152410
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
NCT04755543,NCT03800693,NCT01434069,NCT02319018
|
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00003664,NCT00053807,NCT00053820,NCT00003585
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
GABRA3,MMP9,CXCL8
NCT02969473 |
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
SERPINA6
NCT00181597,NCT00536991,NCT00705822 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00003593,NCT00003331,NCT00003436,NCT02212561
|
Pregnancy/childbirth/puerperium maternal infectionDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB63 |
NCT03607916,NCT02868944,NCT03263689,NCT03036384
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TBXAS1,MMP9,TSHR,CXCL8
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
CXCL8,LMNA,PTGS2,GABRA5
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT04303429,NCT00337389,NCT03426904,NCT04259944,NCT05174169,NCT01238965,NCT00003873,NCT03641976,NCT01111604,NCT04003792,NCT00025337,NCT01383343,NCT00646607,NCT00070122,NCT05179889,NCT01270438,NCT04832776,NCT03883802,NCT00101894,NCT01198548,NCT02510118,NCT01347645,NCT04488159,NCT00003835,NCT02041481,NCT00235898,NCT00942266,NCT02138617,NCT00309530,NCT05062889,NCT04120701,NCT00309543,NCT00004931,NCT00499369,NCT02967289,NCT00079274,NCT01205022,NCT00193219
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT03143153,NCT03368859,NCT03082209,NCT00710736,NCT01332604,NCT02173756,NCT05217069,NCT00634010,NCT05235542,NCT00500292,NCT04533243,NCT05229497,NCT01750918,NCT04243954,NCT02078089,NCT03120403,NCT00803283,NCT02024607,NCT01633970,NCT00479583,NCT01867294,NCT02937116,NCT05332002,NCT00943137,NCT01653470,NCT01046864,NCT05329766,NCT00983541,NCT01183663,NCT04611724,NCT00201539,NCT02640365,NCT04370418,NCT01675622,NCT00941499
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT02383966,NCT01914900,NCT04949256,NCT01181401,NCT04460352,NCT01591135,NCT03387111,NCT03732508,NCT04229459,NCT01542931,NCT04839731,NCT00705016,NCT04926753,NCT05469061,NCT05221658,NCT01627379,NCT04649476,NCT02017600,NCT05125055,NCT02325986,NCT03748134,NCT01836029,NCT01391572,NCT03224221,NCT01248299,NCT04550260,NCT02459457,NCT03370406,NCT03109158,NCT02485548,NCT01225523,NCT03783442,NCT05213312,NCT02218164
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT01526135,NCT04752696,NCT00054873,NCT01676259,NCT02468557,NCT01893294,NCT04990037,NCT04539808,NCT00307723,NCT03806309,NCT04481204,NCT00548548,NCT05314998,NCT03970252,NCT05132504,NCT02178709,NCT04927780,NCT03331640,NCT04821284,NCT02440958,NCT02243007,NCT05325164,NCT04292743,NCT05257993,NCT05209074,NCT03977233,NCT04793932,NCT04469556,NCT02959879,NCT02795988,NCT05472259
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MMP9
NCT02419495,NCT00083109 |
Coronary vasospastic diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA85 |
OPRK1,OPRM1,OPRD1
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
PGR,PTGS2,PTGS1
|
Intentional self-harmDisease Category: 23.External causes of morbidity or mortalityDisease ICD-11 Code: PC91 |
GABRA3,GABRA2,GABRA5
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NR3C2,AR
NCT00590018 |
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
GABRA5,PTGS1,PTGS2
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
OPRM1
NCT02722200,NCT02880540 |
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
CXCL8
NCT03167177,NCT00623766 |
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
NCT01312350,NCT04502641,NCT00508664
|
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
NCT00003078,NCT00023660,NCT00003209
|
ScoliosisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA70.1 |
NCT00737997,NCT03968146,NCT03537612
|
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
NCT03574649,NCT03169738,NCT02419495
|
Status epilepticusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A66 |
NCT02904265,NCT00621478,NCT00004297
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
NCT00002552,NCT00899847,NCT00003331
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
NFKB1,CXCL8,PTGS2
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
OPRD1,GABRB1,CXCL8
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
MMP9,GABRA3,AKR1C3
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
GABRG2,SERPINA6,MMP9
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
GABRA6,CXCL8,GABRA1
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
GABRG2,OPRK1,MMP9
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
GABRG2,HIF1A,LMNA
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
GABRB1,THPO,CXCL8
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
PTGS1,MMP9,AKR1C3
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT00697905,NCT03604965,NCT00677118,NCT00747799,NCT03668730,NCT04004871,NCT01245959,NCT00188877,NCT05433597,NCT00817583,NCT01528618,NCT00201396,NCT02434614,NCT01536223,NCT00816816,NCT02012062,NCT02016417,NCT00816855,NCT03020329,NCT03175939,NCT04834206,NCT00379262,NCT03503136,NCT03306121,NCT02590133,NCT00592501,NCT02500940,NCT03574324,NCT04437329
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT00070122,NCT02508077,NCT03300609,NCT02071069,NCT00079274,NCT03050814,NCT01277406,NCT00707889,NCT02413853,NCT04094688,NCT01605344,NCT01704703,NCT00166465,NCT00967616,NCT00387387,NCT02355379,NCT00003873,NCT00025337,NCT01383343,NCT00499850,NCT00507091,NCT00942266,NCT00003835,NCT00096278,NCT01270438,NCT03069950,NCT00851045,NCT04068103,NCT01862003
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
GABRG2,PTGS2,GLI1,MMP9,AKR1C3,GABRA5,CXCL8
NCT04854499,NCT00274937,NCT00002774,NCT04164238,NCT02268695,NCT02551159,NCT03340896,NCT01233843,NCT03169764,NCT01177956,NCT00971932,NCT00513383,NCT05446467,NCT00736944,NCT00139269,NCT00999700,NCT03855384,NCT01154920,NCT01086826,NCT02047201 |
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
PTGS1
NCT05081687,NCT01736904,NCT00613080,NCT00454116,NCT00009737,NCT00577109,NCT00023751,NCT00023868,NCT00349336,NCT00427310,NCT00749450,NCT01490866,NCT01326000,NCT00039208,NCT01628211,NCT00006366,NCT01765582,NCT00002570,NCT05239741,NCT00020501,NCT05193292,NCT00469443,NCT00321828,NCT00278889,NCT00008281,NCT00280176,NCT02246049,NCT01417494,NCT00612586,NCT01718873,NCT01338558,NCT00537823,NCT00265811,NCT00004005,NCT00016978,NCT00058474,NCT01622543,NCT00952029,NCT01183780,NCT00070213,NCT00016952,NCT01227707,NCT00467142,NCT00268333,NCT00303771,NCT00423696,NCT00110721,NCT00002893,NCT01276379,NCT00003063,NCT00055822,NCT00425152,NCT00016133,NCT02384850,NCT02842580,NCT01442935,NCT02375672,NCT01802645,NCT00025142,NCT02885753,NCT00066846,NCT00284258,NCT00720512,NCT00006015,NCT00642577,NCT00021281,NCT00085163,NCT00112918,NCT00003260,NCT00005979,NCT00061815,NCT00202787,NCT00988897,NCT00002896,NCT00839111,NCT01167725,NCT00427570,NCT00544011,NCT00026364,NCT01479465,NCT01529164,NCT00143403,NCT01418222,NCT00002551,NCT00862784,NCT00003287,NCT00016198,NCT00006786,NCT00335816,NCT00647530,NCT00378716,NCT00385021,NCT00002793,NCT00286000,NCT01279681,NCT00609622,NCT00755118,NCT00354978,NCT00786643,NCT00002593,NCT00291785,NCT01193452,NCT00889343,NCT00501410,NCT00027833,NCT02376452,NCT01442649,NCT00182715,NCT00004150,NCT00003422,NCT00091312,NCT05253651,NCT00940303,NCT01205711,NCT00866944,NCT00069095,NCT00384176,NCT00199797,NCT00262808,NCT01271166,NCT00719199,NCT00671372,NCT00026273,NCT00002525,NCT00268398,NCT01465451,NCT00006103,NCT02124148,NCT01374425,NCT01515787,NCT00001428,NCT00497497,NCT04337879,NCT00005050,NCT00066274,NCT00006115,NCT00006468,NCT00049101,NCT00831181,NCT01133990,NCT01077739,NCT01375816,NCT00615056,NCT00002716,NCT05035381,NCT00958737,NCT00323011,NCT01047293,NCT00004102,NCT00551213,NCT02515734,NCT00003594,NCT01679327,NCT02291289,NCT01286818,NCT00080951,NCT00004885,NCT00070434,NCT00006037,NCT00005586,NCT00797485,NCT00075595,NCT00069121,NCT00449137,NCT01226719,NCT00212589,NCT00640081,NCT02494973,NCT01289821,NCT02415699,NCT00081289,NCT00064181,NCT00111761,NCT00003446,NCT00778102,NCT00813137,NCT00478946,NCT00003001,NCT00209703,NCT00021398,NCT03487939,NCT00118261,NCT00003543,NCT02826837,NCT01478594,NCT02244632,NCT00072553,NCT00098787,NCT00884767,NCT01263171,NCT00556413,NCT00388700,NCT01652482,NCT00973609,NCT00065117,NCT00873275,NCT00202774,NCT00571740,NCT00296608,NCT00002692,NCT00003254,NCT00046995,NCT00559741,NCT00098982,NCT00265850,NCT00126256,NCT00006479,NCT00176774,NCT02141295,NCT01383707,NCT00541125,NCT00008060,NCT00077233,NCT01836653,NCT00274872,NCT00719797,NCT02830139,NCT00002523,NCT00069108,NCT00336960,NCT00541112,NCT01068132,NCT00002828,NCT00062426,NCT00020917,NCT00004252,NCT01150045,NCT00209625,NCT00628810,NCT00721916 |
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00133991,NCT00019409,NCT00618501,NCT00003728,NCT00002494,NCT00003436,NCT00002865,NCT00004034,NCT00002704,NCT00400946,NCT00005802,NCT00002785,NCT00002756,NCT00002805,NCT00003593,NCT00002757,NCT00002816,NCT00002700,NCT00002744,NCT00002471
|
AlopeciaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED70 |
PTGDR2,AR
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO,MMP9
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A,NR3C2
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NR3C1
NCT01064986 |
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
CoughDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD12 |
OPRM1,OPRD1
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NFKB1,CXCL8
|
Inflammatory spondyloarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA92 |
PTGS2,PTGS1
|
Cerebral ischaemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B1Z |
PTGS1,PTGS2
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NR3C1,PTGDR2
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
NR3C1
NCT00980876 |
Joint painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME82 |
PTGS1,PTGS2
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NR3C2,AR
|
Hypo-osmolality/hyponatraemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C72 |
AR,NR3C2
|
Tension-type headacheDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A81 |
GABRA1,OPRM1
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
SERPINA6,NR3C1
|
Otitis mediaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA80-AB0Z |
PTGS1,PTGS2
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NR3C1,PTGDR2
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
HIF1A,MMP9
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
PTGS1,PTGS2
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NFKB1,NR3C1
|
Hyper-lipoproteinaemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
PTGS2,PTGS1
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
NR3C1,GABRA5
|
Respiratory system diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB40-CB7Z |
SERPINA6,PTGDR2
|
Reactive arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA11 |
PTGS2,PTGS1
|
Corneal diseaseDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A76-9A78 |
OPRM1,GABRA1
|
Urinary system diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC2Z |
PTGS1,PTGS2
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
PTGS1,PTGS2
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
OPRM1,PTGS1
|
Inherited coagulation factor deficiencyDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B14 |
PTGS2,PTGS1
|
Bowel habit changeDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05 |
OPRM1,OPRD1
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
PTGS2,PTGS1
|
Tonus and reflex abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB47 |
GABRA1,GABRG2
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
AR,TBXAS1
|
Acquired adrenocortical insufficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A74.0 |
NCT01847690,NCT01063569
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00526110,NCT00208936
|
PneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40 |
NCT02517489,NCT02735707
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT03167164,NCT00003549
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
NCT02735707,NCT01014364
|
Neoplasms of unknown behaviour of larynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F91.0 |
NCT00117572,NCT00599131
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT02777437,NCT03484195
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT03736720,NCT03042780
|
Obstructive sleep apnoeaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A41 |
NCT01680939,NCT02014714
|
Intrahepatic cholangiocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.10 |
NCT03771846,NCT04961970
|
Acute leukaemias of ambiguous lineageDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A61 |
NCT02419755,NCT04898894
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT03197584,NCT00004206
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
NCT00006111,NCT00003175
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT03013218,NCT03169790
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT00084838,NCT01498783
|
Rotator cuff syndromeDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB53.1 |
NCT03818919,NCT03034382
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT02710734,NCT04241185
|
Bronchopulmonary dysplasia originating in the perinatal periodDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KB29.0 |
NCT00004669,NCT00623740
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT02879513,NCT01880385
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
NCT00001569,NCT00352755
|
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
NCT00117572,NCT00117572
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT01399268,NCT00217737
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
NCT02767219,NCT00000122
|
Non-alcoholic steatohepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.1 |
CXCL8,PTGS2
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
GABRB1,TSHR
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
MMP9,CXCL8
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CXCL8,PTGS2
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
OPRK1,PGR
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
PTGS1,OPRK1,PTGS2,CXCL8,OPRM1,OPRD1,ADRA2A
NCT01979354,NCT01053039,NCT02511483,NCT02044302,NCT01082471,NCT04527393,NCT02731430,NCT01522534,NCT03648008,NCT00672347,NCT00374881,NCT00305058,NCT04752033,NCT00213200,NCT00155233,NCT03068260,NCT05281081,NCT01071499,NCT00766506,NCT02954484,NCT00195910,NCT02300194,NCT02223533,NCT01966172,NCT01938092,NCT02137525,NCT01304212,NCT02353754,NCT03622489,NCT03005548,NCT01830296,NCT05037539,NCT00728832,NCT03639389,NCT02434939,NCT03151863,NCT05186454,NCT01079754,NCT02302586,NCT03012971,NCT02790099,NCT00795223,NCT00558870,NCT01953978,NCT04582786,NCT01038609,NCT01866254,NCT02935972,NCT05099055,NCT03017248,NCT00681174,NCT03534869,NCT03675646,NCT01835262,NCT03007121,NCT00237731,NCT04061330,NCT01077752,NCT03117595,NCT01526525,NCT01084161,NCT03472469,NCT04369950,NCT03238430,NCT02669004,NCT00528177,NCT02815709,NCT01080911,NCT02749162,NCT03095222,NCT04755712,NCT01298297,NCT02673372,NCT02726828,NCT05308420,NCT02410317,NCT02115087,NCT00385541,NCT02264821,NCT02936934,NCT02145975,NCT03098420,NCT05338320,NCT03428633,NCT01882530,NCT03254459,NCT01094522,NCT02100748,NCT01322191,NCT02152514,NCT03288428,NCT03257319,NCT01844206,NCT02523846,NCT02620631,NCT02456142,NCT03383588,NCT01975753,NCT00266539,NCT00996177,NCT01933542,NCT00121563,NCT04794738,NCT00820027,NCT05218733,NCT03774836,NCT05375305,NCT02848729,NCT02820324,NCT03875274,NCT02817477,NCT02151682,NCT03592992,NCT00390312,NCT03579446,NCT03035578,NCT04887649,NCT02687347,NCT02282956,NCT03713216,NCT01686802,NCT02530151,NCT02096003,NCT02435537,NCT05413902,NCT02716129,NCT00772187,NCT00264485,NCT00362219,NCT02460913,NCT02976597,NCT03241485,NCT02335294,NCT03063359,NCT01790555,NCT02912195,NCT03224039,NCT00349401,NCT02483221,NCT04849455,NCT00478023,NCT02083315,NCT00390039,NCT02248493,NCT02677532,NCT00872885,NCT00136682,NCT00803114,NCT01245244,NCT03088306,NCT02698995,NCT00609466,NCT03730714,NCT02111746,NCT03236805,NCT03404908,NCT02279628,NCT00346268,NCT01951963,NCT03502642,NCT00287326,NCT03570541,NCT04852003,NCT02746263,NCT02095366,NCT04766463,NCT02009722,NCT00656773,NCT01918917,NCT03843281,NCT01304134,NCT01539538,NCT01465191,NCT00142519,NCT01057381 |
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT04919226,NCT04325425,NCT03387592,NCT03164382,NCT00953394,NCT01524094,NCT00001569,NCT05015621,NCT02820857,NCT03837977,NCT01489566,NCT01858025,NCT00003558,NCT02172976,NCT03168607,NCT00022178,NCT03092895,NCT02246127
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NR3C1,AKR1C3,AR
NCT00953576,NCT01367418,NCT00002881,NCT00027859,NCT00006371,NCT01036594,NCT00002760,NCT00673127,NCT00002855,NCT00309894,NCT00895310,NCT03261336,NCT00859781,NCT00460031 |
Epilepsy/seizureDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A61-8A6Z |
GABRA1,GABRG2
NCT00319501,NCT02721069,NCT00326612,NCT01417078,NCT01364558,NCT02316847,NCT05361447,NCT02724423,NCT03953820,NCT02474407,NCT05076838,NCT03428360,NCT03179891,NCT03222349 |
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
GABRA3,SERPINA6,MMP9,CXCL8
NCT04675983,NCT00183911,NCT03959293,NCT03281369,NCT04510064,NCT01567618,NCT02625610,NCT05268510,NCT04908566,NCT04523818,NCT02545504,NCT02494583 |
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT01186328,NCT02212561,NCT03913559,NCT00165178,NCT03020030,NCT00098839,NCT02535806,NCT02043587,NCT03817320,NCT02303821,NCT02419755,NCT00136435,NCT00131053,NCT02101853,NCT00176462,NCT03349281
|
Opioid use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43 |
ADRA2A,OPRM1,OPRD1,OPRK1
NCT03678792,NCT04448561,NCT03948464,NCT01718964,NCT04231708,NCT00142896,NCT01136356,NCT03015246,NCT04181515,NCT00000335,NCT00460239 |
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
GABRG2,GABRA3,GABRA1,OPRD1,OPRK1,PTGS1,GABRA2,TBXAS1,SERPINA6,MMP9,PTGS2,TSHR,GABRA5,CXCL8
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT03785873,NCT03110510,NCT04005339,NCT01127555,NCT04217954,NCT05052099,NCT04722133,NCT01572324,NCT03291899,NCT03524508,NCT00090025,NCT03778593,NCT01494363
|
Malignant neoplasms of anus or anal canalDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
NCT00955240,NCT00423293,NCT00068744,NCT00003596,NCT02369939,NCT01324141,NCT00324415,NCT00003652,NCT00025090,NCT01621217,NCT02402842,NCT02059499,NCT00316888
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
GABRG2,GABRA3,NR3C1,GABRA1,OPRD1,GABRB1,OPRK1,PTGS1,GABRA2,OPRM1,PTGDR2,MMP9,GABRA5
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
GABRG2,GABRA3,PTGS2,GABRB3,PTGS1,GABRA2,TBXAS1,GLI1,HIF1A,CXCL8,AKR1C3,LMNA,PGR
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT04390399,NCT00003018,NCT00059826,NCT01867892,NCT01836432,NCT02351219,NCT03042780,NCT00005870,NCT00058201,NCT01632306,NCT00002955,NCT01446458,NCT02128100,NCT00424827,NCT00262951,NCT03563248,NCT02551991,NCT01485744,NCT05065801,NCT02676349,NCT01661088,NCT01905150,NCT02021422,NCT01888978,NCT00003029,NCT04807972,NCT02672917,NCT01821729,NCT03991962,NCT05462496,NCT00068575,NCT05047991,NCT03484299,NCT03504423,NCT01560949,NCT04431258,NCT00417976,NCT04161755,NCT01523457,NCT04897854,NCT00463840,NCT02717091,NCT02241551,NCT00010062,NCT03136406,NCT01688336,NCT03387098,NCT00112697,NCT02028806,NCT00323583,NCT02405585,NCT02581215,NCT00303758,NCT02355119,NCT00251355,NCT01992705,NCT05466799,NCT01473303,NCT00609765,NCT00003216,NCT03443492,NCT03883919,NCT02539537,NCT04594772,NCT04324307,NCT02923921,NCT00002689,NCT04371224,NCT01488552,NCT05360732,NCT00026130,NCT00004003,NCT01494506,NCT01489865,NCT00602602,NCT03760614,NCT02311439,NCT03861702,NCT00416507,NCT04084496,NCT00003049,NCT00112658,NCT00436267,NCT00660270,NCT03336216,NCT00024427,NCT00033735,NCT01063192,NCT04672005,NCT01591733,NCT02352337,NCT00005871,NCT04769414,NCT03586869,NCT03693677,NCT02506842,NCT04089150,NCT02827201,NCT00960284,NCT00275119,NCT00786006,NCT00045747,NCT01652976,NCT00601627,NCT03899636,NCT03699319,NCT03600623,NCT03329248,NCT01754623,NCT04228601,NCT03487016,NCT02919787,NCT00049348,NCT02574663,NCT01827553,NCT03941093,NCT01454180,NCT05251038,NCT04589234,NCT00089024,NCT03167112,NCT03563144
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
HIF1A
NCT00003956,NCT00392834,NCT00003215,NCT00003728,NCT00133991,NCT00001579,NCT00002757,NCT00002494,NCT00002700,NCT00006455,NCT00002471 |
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
GABRA3,GABRA1,OPRD1,GABRB1,SMN1,GABRA2,PTGS1,GLI1,TBXAS1,LMNA,MMP9,GABRA5
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
GABRG2,GABRA3,GABRA2,PTGDR2,GLI1,MMP9,AKR1C3,GABRA3,GABRA2,PTGDR2,MMP9,AKR1C3
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
GABRG2,GABRA3,OPRD1,SMN1,PTGS1,GLI1,TBXAS1,SERPINA6,HIF1A,CXCL8,GABRB3,GABRA5
|
Congenital adrenal hyperplasiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71.01 |
NCT03062280,NCT01735617,NCT03019614,NCT01771328,NCT00621985,NCT03548246,NCT00001521,NCT01859312,NCT00519818,NCT05063994,NCT02096510
|
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT02281682,NCT03037541,NCT01354717,NCT00377273,NCT01525329,NCT02289768,NCT02616601,NCT05078827,NCT02019355,NCT04875026,NCT00696488
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
GABRA3,OPRD1,GABRB1,PTGDR2,GLI1,MMP9,PGR
NCT00003994,NCT00980460,NCT04478292,NCT03017326 |
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT01111604,NCT01554059,NCT00006094,NCT02921256,NCT03975049,NCT01238965,NCT00832299,NCT01060007,NCT02704520,NCT02217020,NCT04423965,NCT03000374,NCT00337389,NCT01740648,NCT03428529,NCT00052559,NCT03781323,NCT03259035,NCT02280070,NCT03085992,NCT05108428,NCT01500993,NCT05412082,NCT05378919,NCT01650428,NCT05111860,NCT03921684,NCT01274962,NCT04170530,NCT00278694,NCT04009876,NCT03299660,NCT04165772,NCT01197664,NCT00865189,NCT00321685,NCT00145769,NCT03300544,NCT03484221,NCT04418895,NCT00235898,NCT05358704,NCT00527111,NCT02008656,NCT01376453,NCT03043729,NCT03443661,NCT00070122,NCT00303628,NCT03548961,NCT01302613,NCT04838496,NCT03879109,NCT05074966,NCT04808323,NCT04380337,NCT02574663,NCT01269216,NCT02423226,NCT00307736,NCT04215731,NCT03671252,NCT00580073,NCT00807911,NCT01205022,NCT02340949,NCT00422864,NCT00003799,NCT00003873,NCT02319304,NCT03161574,NCT00611858,NCT00499369,NCT04130854,NCT02041481,NCT03127007,NCT01211210,NCT05022030,NCT02514278,NCT00025337,NCT01716949,NCT01347645,NCT02941562,NCT02887313,NCT05009069,NCT01871571,NCT05253846,NCT02167321,NCT01013805,NCT01270438,NCT02942563,NCT00707889,NCT02270606,NCT00942266,NCT03152370,NCT04621370,NCT00101894,NCT02465593,NCT01269229,NCT03391843,NCT05024097,NCT01198548,NCT01481545,NCT04495088,NCT00349076,NCT02688712,NCT01941641,NCT05201430
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
PGR,NR3C1,AR
NCT03554109,NCT00047099,NCT04127019,NCT02393833,NCT00431080,NCT00688740,NCT00038402,NCT00309569,NCT00124111,NCT00309478,NCT03175666,NCT02846428,NCT00087178,NCT02132949,NCT02400567,NCT02897700,NCT00002542,NCT00015886,NCT02115152,NCT02115204,NCT00036868,NCT00152191,NCT00129389,NCT02897050,NCT01036087,NCT00002870,NCT00002498,NCT00012311,NCT02681003,NCT00625898,NCT00433420,NCT00152178,NCT00301925,NCT01216111,NCT01270373,NCT00773695,NCT00014222,NCT00002696,NCT00055679,NCT00002784,NCT00776724,NCT03387085,NCT02450058,NCT00005581,NCT02980965,NCT00002579,NCT03888677,NCT01642771,NCT01593020,NCT02225652,NCT04031703,NCT00017095,NCT00053911,NCT01855828,NCT00950300,NCT00003086,NCT00615602,NCT01985724,NCT00003577,NCT00003680,NCT00003013,NCT00311636,NCT01966471,NCT00559845,NCT01358877,NCT01031030,NCT00499603,NCT01222052,NCT00002582,NCT00003893,NCT00336791,NCT00872625,NCT00525759,NCT00002580,NCT00820547,NCT00129922,NCT02742051,NCT00963729,NCT00533936,NCT00331097,NCT00003012,NCT00630032,NCT02995772,NCT01937507,NCT00001498,NCT00193011,NCT00929591,NCT00629278,NCT02365805,NCT01314833,NCT01985841,NCT00756470,NCT01231802,NCT00054587,NCT00033683,NCT00010075,NCT00002581,NCT00002755,NCT01204437 |
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
PTGS2,OPRM1,GABRA1,OPRK1,OPRD1
NCT02462577,NCT05187520,NCT03275012,NCT00383682,NCT02935933 |
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
GABRG2,TBXAS1,GABRA2,PTGS1,GABRA5,GABRA1,GABRA3,PTGS2,NR3C1,NFKB1
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
PTGDR2
|
Menstrual cycle bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20 |
PGR
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
GABRA1
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
NFKB1
|
Liver vascular disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB98 |
GABRA1
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
OPRK1
|
Choreiform disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A01 |
NFKB1
|
Preterm labour/deliveryDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JB00 |
PGR
|
Chronic insomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00 |
GABRA1
|
Low bone mass disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB83 |
AR
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
NR3C1
|
PrurigoDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EC91 |
OPRK1
|
Spine/trunk injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51 |
NR3C1
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MMP9
|
Prostate hyperplasiaDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA90 |
AR
|
Acute respiratory distress syndromeDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB00 |
GABRA1
|
CystitisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC00 |
GABRA1
|
Large intestine motility disorderDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB32 |
OPRM1
|
Uterine fibroidDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E86 |
PGR
|
Alcoholic liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB94 |
AR
|
Functional bladder disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GC50 |
OPRD1
|
Acute/subacute hepatic failureDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB91 |
NFKB1
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
NR3C1
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
PTGDR2
|
General pain disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43 |
OPRM1
|
Acne vulgarisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED80 |
AR
|
Skin sensation disturbanceDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME65 |
OPRM1
|
Mammary tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Z |
AR
|
Muscle disorderDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FB32-FB3Z |
AR
|
Adrenogenital disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71 |
NR3C1
|
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
MMP9
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
PTGS1
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
AR
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
PTGS1
|
Ataxic disorderDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A03 |
PTGS1
|
Mental/behavioural/neurodevelopmental disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6E20-6E8Z |
OPRM1
|
Lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40 |
NFKB1
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
NR3C1
|
Vitamin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55-5B5F |
NR3C1
|
Digestive system diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
OPRM1
|
Sleep-wake disorderDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7B2Z |
GABRA3
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
PGR
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
PTGS1
|
Testicular dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A81 |
AR
|
Mild neurocognitive disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D71 |
GABRA5
|
Breathing abnormalityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11 |
OPRM1
|
Sex development malformative disorderDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2A |
GABRA5
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR
|
Eye anterior segment structural developmental anomalyDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA11 |
PTGS1
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
NR3C1
|
Skin and skin-structure infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F28-1G0Z |
NFKB1
|
Non-specific cutaneous vascular symptonDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME64 |
OPRK1
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
PTGS1
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
Knee osteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA01 |
PTGS2
|
Binge eating disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B82 |
OPRM1
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
GABRA1
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
GABRA5
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
TBXAS1
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
ADRA2A
|
Acute painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG31 |
OPRM1
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT03541252
|
AsphyxiaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.1 |
NCT04348305
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT02419495
|
Haemorrhage, not elsewhere classifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG27 |
NCT02622126
|
Acute repetitive seizuresDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A67 |
NCT00319501
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
NCT03933397
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Cerebral palsy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D2Z |
NCT04523935
|
Mucinous adenocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1S75 |
NCT00068692
|
Herpes simplex labialisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00.01 |
NCT01574612
|
Gastrointestinal stromal tumourDisease Category: X.Extension CodesDisease ICD-11 Code: XH9HQ1 |
NCT02574663
|
Acute monocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH9NE2 |
NCT00002798
|
Primary haemophagocytic lymphohistiocytosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01.23 |
NCT01104025
|
Malignant neoplasms of larynx, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C23.Z |
NCT00508664
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT02602210
|
Burkitt-like lymphoma with 11q aberrationDisease Category: X.Extension CodesDisease ICD-11 Code: XH8NN2 |
NCT00873093
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00625092
|
Disorders of oral mucosaDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01 |
NCT01837446
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00002524
|
Acute myelomonocytic leukaemiaDisease Category: X.Extension CodesDisease ICD-11 Code: XH78Y4 |
NCT00002798
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02419495
|
skin carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C31.0-2E67.40 |
NCT02218164
|
Refractory anaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A30 |
NCT00002798
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT03682393
|
Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62.Z |
NCT03237689
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT00220454
|
Dermatitis or eczema, unspecifiedDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA8Z |
NCT00375713
|
Alcohol dependenceDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40.2 |
NCT02196142
|
Fracture of unspecified body regionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56.2 |
NCT03473093
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
NCT00482053
|
Chronic widespread painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30.01 |
NCT00236925
|
Type1diabetesmellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A10 |
NCT01265017
|
Anaplastic large cell lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1LC0 |
NCT00354107
|
Fractures involving multiple body regionsDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND32 |
NCT01807429
|
Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associatedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90.5 |
NCT03007147
|
Alopecia areataDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED70.2 |
NCT01453686
|
Acquired epileptic aphasiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A62.2 |
NCT02904265
|
Neuropathic painDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E43.0 |
NCT01914042
|
Preterm newborn, unspecifiedDisease Category: 19.Certain conditions originating in the perinatal periodDisease ICD-11 Code: KA21.4Z |
NCT00494429
|
Oral mucositisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01 |
NCT02252926
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
NCT00002798
|
SchizophreniaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20 |
NCT02374567
|
Acute myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41 |
NCT01186445
|
Nicotine use disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C4A |
NCT03670212
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03323463
|
Acute erythroid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.35 |
NCT00002798
|
Malignant neoplasms of nasal cavityDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C20 |
NCT00117572
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT02419495
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT01498783
|
RestlessnessDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.F |
NCT03246620
|
Personality disorder, severity unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D10.Z |
NCT03209102
|
Depressive disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A7Z |
NCT02374567
|
Other specified disorders of the nervous systemDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E4Y |
NCT02804022
|
PancreatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC31-DC34 |
NCT05160506
|
Insulin-resistance syndromesDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A44 |
NCT02256865
|
Retention of urineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MF50.3 |
NCT02848599
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT00000758
|
Diseases of the musculoskeletal system or connective tissueDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 15 |
NCT00244153
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT03197571
|
Age-associated cognitive declineDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB21.0 |
NCT01828515
|
CholelithiasisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC11 |
NCT00784472
|
DementiaDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6D80-6D8Z |
NCT02374567
|
Signet ring cell carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4546 |
NCT00217737
|
Malignant neoplasms of other or unspecified parts of biliary tractDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT05350943
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT01014364
|
Squamous intraepithelial neoplasia, high gradeDisease Category: X.Extension CodesDisease ICD-11 Code: XH3EA2 |
NCT02059499
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003331
|
Fracture of ribDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA82.3 |
NCT02749409
|
DyspnoeaDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MD11.5 |
NCT04188418
|
Mast cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21.00 |
NCT00186628
|
HypotensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA20-BA21 |
NCT00358748
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00849264
|
Oral submucous fibrosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA02.2 |
NCT02714543
|
ConstipationDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME05.0 |
NCT01533155
|
Opioid dependence, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C43.2Z |
NCT03015246
|
Allergic conjunctivitisDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A60.02 |
NCT01860664
|
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
NCT02591030
|
Adrenal cortical carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4KH2 |
NCT00002921
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT02419495
|
Malignant neoplasms of corpus uteriDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT00782041
|
Chalazion, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.0Z |
NCT02025023
|
Refractory anaemia with excess of blastsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A35 |
NCT00002798
|
Anxiety or fear-related disorders, unspecifiedDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6B0Z |
NCT01574014
|
Acute megakaryoblastic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60.36 |
NCT00002798
|
Restless legs syndromeDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A80 |
NCT01476124
|
Low back painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: ME84.2 |
NCT02646124
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
NCT00003593
|
HaemorrhoidsDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB60 |
NCT01913158
|
Blood-forming organ diseaseDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3C0Z |
NCT02622126
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT02590367
|
Other specified acute tonsillitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA03.Y |
NCT01691690
|
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
MMP9
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
MMP9
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CXCL8
|
Malignant neoplasms of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
PTGS2
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
MMP9
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
MMP9
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
MMP9
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
GABRB1
|
Malaria, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F4Z |
MMP9
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
PTGS2
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MMP9
|